Índice

• Sociedad Chilena de Urologia

  • ·SCHU-01: VEGF165b, an Inhibitory Splice Variant of VEGF165 in Transitional Cell Carcinoma of the Bladder: In Vivo Expression

    Página :S3

    S. Gopi, M. H-Zadeh, C. Sen, S. Harper, D. Bates, D. Gillatt

    Esquema Esquema
  • ·SCHU-02: The Role of Steroid Hormones in Female Bladder Outlet Obstruction and in a Rat Model

    Página :S3

    Z. Shen, Y. Yu, Y. Zhou, X. Zhou, S. Chen

    Esquema Esquema
  • ·SCHU-03: Novel Biomarkers in Prostate Cancer Detection

    Página :S3

    E. Johnson, S. Smith, C. Probert, N. Ratcliffe, R. Persad

    Esquema Esquema
  • ·SCHU-04: Radical Retropubic or Perineal Prostatectomy Worsens the Quality of Life of Cancer Patients at Six-Month Follow-Up

    Página :S3

    I.M.D. Sanches, C. Andreoni, I. Carmagnani, H. De Arruda, V. Orriz

    Esquema Esquema
  • ·SCHU-05: Neuroanatomical Study of Periprostatic Nerve Distribution in Human Cadaver Prostates

    Página :S4

    K.S. Han, W. Sung, K.H. Yoo, S.G. Chang

    Esquema Esquema
  • ·SCHU-06: Neuroendocrine Carcinoma of the Prostate: A Poor Prognosis?

    Página :S4

    A. Foneron, O. Castillo, M. García, M. Feria, M. Gonzalez, R. Campos, I. Vidal

    Esquema Esquema
  • ·SCHU-07: Is Routine Prostate Biopsy a Reliable Predictor of Laterality and Pathological Features in Early Stage Low-Risk Prostate Cancer?

    Página :S5

    A. Domenech, C. Diaz, A. Figueroa, G. Rubio, G. Fredes, C. Falcon, A. Krebs, M. Zambrano, J. Prieto, L.F. Coz

    Esquema Esquema
  • ·SCHU-08: Prognostic Factors in Transrectal Prostate Ultrasound-Guided Biopsy in Radical Prostatectomy Patients

    Página :S5

    C. Acevedo, C. Huidobro, J. Cabezas, J. Fullá, M. Varas, B. Huidobro, V. Galleguillos

    Esquema Esquema
  • ·SCHU-09: Benign Prostatic Hyperplasia (BPH) and Prostatic Cancer (PC) Aminopeptidasis

    Página :S5

    S. Oliveira-Montanaro, H. de Arruda, É. Sugimoto, M. Teixeira, M. Bavaresco, K. Alves, L. Oliveira

    Esquema Esquema
  • ·SCHU-10: Influence of Body Mass Index on Serum PSA Concentration in Prostate Cancer Screening

    Página :S6

    J.D. Lopez Laur, R. Pérez Elizalde, N. Di Milta, G. Recalde, M. Vanrell, M. Maselli, C. López Fontana

    Esquema Esquema
  • ·SCHU-11: Laparoscopic Radical Cystectomy in Muscle Invasive Bladder Cancer: A Single Centre Experience

    Página :S6

    M. Desai, A. Ganpule, K. Shah, R. Sabnis, V. Muthu

    Esquema Esquema
  • ·SCHU-12: Laparoscopic Radical Nephrectomy Versus Open Radical Nephrectomy: A Contemporary Outcome Analysis

    Página :S6

    M. Desai, A. Ganpule, R. Sharma, R. Sabnis, V. Muthu

    Esquema Esquema
  • ·SCHU-13: Percutaneous Radiofrequency Ablation (RFA) of Renal Tumors

    Página :S7

    E. Johnson, M. Callaway, H. Roach

    Esquema Esquema
  • ·SCHU-14: High Intensity Focused Ultrasound Renal Tissue Ablation: A Laparoscopic Porcine Model

    Página :S7

    M. Orvieto, K. Zorn, A. Shalhav

    Esquema Esquema
  • ·SCHU-15: Our Experience with Laparoscopic Partial Nephrectomy

    Página :S7

    J.M. Campero, C. Ramos, A. Hinrichs, N. Zambrano, R. Rosenfeld, A. Miranda, E. Alvarez

    Esquema Esquema
  • ·SCHU-16: Retroperitoneoscopic Surgery for Adrenal Microlesions: Our Experience

    Página :S7

    Z.J. Shen, X. Wang, Y. Zhu, R.M. Zhang, F.K. Sun, Y. Shao, W.B. Rui, W. He

    Esquema Esquema
  • ·SCHU-17: Retroperitoneal Laparoscopic Radical Nephrectomy: Our Initial Experience

    Página :S8

    V. Moraga, A. Vidal, A. Estrugo, R. Morales, H. Flores

    Esquema Esquema
  • ·SCHU-18: Embryonal Rhabdomyosarcoma of the Urachus Presenting as Acute Abdomen: A Case Report

    Página :S8

    N. Letelier, A.M. Castillo, R. Zubieta, P.J. López, R. Gana, G. Retamal

    Esquema Esquema
  • ·SCHU-19: Results of a Conservative Approach in Pyeloureteral Tumors

    Página :S8

    R.G. Bengio, M. El Hay, V. Bengio, S.D.B. Orellana, L. Arribillaga, R.H. Bengio

    Esquema Esquema
  • ·SCHU-20: E-Cadherin Predictive Value for Recurrence of Bladder Noninvasive Tumors (Ta-T1)

    Página :S9

    R.G. Bengio, V. Bengio, L. Arribillaga, M. El Hay, S.D.B. Orellana, R.H. Bengio

    Esquema Esquema
  • ·SCHU-21: Uroflowmetry Alterations in Women with Stress Urinary Incontinence

    Página :S9

    J.M. Flores, T. Olmedo, O. Storme, M. Olea, J. Fulla, D. Varas, C. Hudson, M. Varas

    Esquema Esquema
  • ·SCHU-22: Urethral Stricture: Our Experience

    Página :S9

    O. Castillo, M. Feria, A. Foneron, I. Vidal, R. Campos

    Esquema Esquema
  • ·SCHU-23: Ostomy Problems with Catheterizable Continent Reservoirs

    Página :S10

    G. Catalan, R. Gomez, P. Marchetti

    Esquema Esquema
  • ·SCHU-24: Sex-Related Differences in Gene Expression in the Pre-puberal and Puberal Mouse Bladder

    Página :S10

    Y. Yu, Z. Shen, Z. Sun, B. Wang, L. Shortliffe

    Esquema Esquema
  • ·SCHU-25: Complication Rate of Suburethral Tape Techniques in the Treatment of Stress Incontinence

    Página :S10

    P. Rivera, J. Medina, M.J. Navas

    Esquema Esquema
  • ·SCHU-26: Tubeless Percutaneous Renal Surgery in the Supine Position: Initial Experience

    Página :S11

    A. Vidal, B. Silva, F. Vargas, P. Valdebenito, F. Araya, J. De la Torre, E. Maldonado

    Esquema Esquema
  • ·SCHU-27: Transurethral Bulking Agent Injection: Promissory Results Using the New “Vantris” Macroparticle in the Treatment of Stress Urinary Incontinence

    Página :S11

    T. Olmedo, M.A. Zangone, S. Gomez, C. Guichard, C. Palma, O. Storme, F. Osorio, J. Benavides

    Esquema Esquema
  • ·SCHU-28: Pheochromocytoma in Children: Is Laparoscopic Adrenalectomy Safe?

    Página :S11

    F.T. Dénes, R.F. Coelho, M. Machado, B.B. Mendonça, M. Srougi

    Esquema Esquema
  • ·SCHU-29: Notch-3 and Notch-4 in the Development of a Normal Prostate Gland in a Mouse

    Página :S11

    E. Milla, G. Venegas, J. Inostroza, E. Ossandon, M. Cuevas, C. Vega, H. Rodríguez

    Esquema Esquema
  • ·SCHU-30: Prognostic Factors for Survival After Radical Nephroureterectomy in Upper Tract Urothelial Carcinoma: Analysis of a Large Hispanic Multicentric Series

    Página :S12

    M. Fernández, M. Schultz, A. Krebs, A. Whalton, O. Storme, S. Guzmán, F. Marchant, I. Delgado, P. Bernier, L.F. Coz

    Esquema Esquema
  • ·SCHU-31: Percutaneous Renal Surgery in the Valdivia Uria Position: Our Experience in 70 Cases

    Página :S12

    B. Silva, A. Vidal, F. Vargas, P. Valdebenito, F. Araya, J. De la Torre, E. Maldonado

    Esquema Esquema
  • ·SCHU-32: Pathologic Features of Solid Renal Tumors Measuring Less Than 4 cm

    Página :S13

    G. Rubio, O. Castillo, C. Diaz, F. Hidalgo, I. Vidal

    Esquema Esquema
  • ·SCHU-33: Efficacy of the Argon Beam Coagulator Alone in Obtaining Hemostasis After Laparoscopic Porcine Heminephrectomy: A Pilot Study

    Página :S13

    M. Orvieto, A. Lucioni, K. Zorn, A. Shalhav

    Esquema Esquema
  • ·SCHU-34: Comparison of Clinical Factors, Surgical Complications, Functional Results and Quality of Life Among Four Different Types of Urinary Diversion

    Página :S13

    Genta M. Navarro, Alegría R. Tagle, Miranda J. Montes, C. Barría

    Esquema Esquema
  • ·SCHU-35: Complications Related to the Use of Intestinal Mechanic Sutures in Urinary Procedures

    Página :S14

    P. Marchetti, R. Gómez, G. Catalán

    Esquema Esquema
  • ·SCHU-36: Open vs. Laparoscopic Enterocystoplasty

    Página :S14

    R. Gomez, O. Castillo, P. Marchetti, G. Catalan

    Esquema Esquema
  • ·SCHU-37: Decreased Mortality in Testicular Cancer: Survival Analysis in Two Chilean Medical Centers

    Página :S15

    C. Parra, L. Parada, P. León, F. Sanhueza, J. Domínguez, A. Dell'Oro, P. Gonzalez

    Esquema Esquema
  • ·SCHU-38: Endourological Management of Ureteroenteric Strictures

    Página :S15

    I. Vidal, O. Castillo, M. González-Morales, A. Foneron, M. García, M. Feria, J. Medina, R. Campos

    Esquema Esquema
  • ·SCHU-39: Use of a Stent for Lower Ureteral Stones in Ureteroscopy: A Prospective Randomized Study

    Página :S15

    P. Acuña, A. Cruzat, A. Giacaman, P. Acuña-Valenzuela

    Esquema Esquema
  • ·SCHU-40: Continent Reconstructive Surgery of the Neurogenic Bladder

    Página :S16

    R. Gomez, P. Marchetti, G. Catalan

    Esquema Esquema
  • ·SCHU-41: Complications in Percutaneous Nephrolithotomy: A Comparative Study Between the Supine and Prone Positions Using the Modified Clavien System

    Página :S16

    A. Domenech, B. Vivaldi, C. Diaz, M. Fernandez, A. Figueroa, A. Krebs, N. Zambrano, F. Coz

    Esquema Esquema
  • ·SCHU-42: Demucosed Colocystoplasty Preserving the Urothelium: Our Experience

    Página :S16

    E.O. Arias, R.P. Yañez

    Esquema Esquema
  • ·SCHU-43: Treatment of Non-metastatic Rhabdomyosarcoma of the Prostate in Childhood and Adolescence: The Role of Surgery

    Página :S17

    J. López, V. Durán, C. Burek, J. Corbetta, M. Dávila, A. Rosé, R. Dingevan, C. Sager, E. Perazzo

    Esquema Esquema
  • ·SCHU-44: Changes in Urinary Symptoms Following I-125 Prostate Brachytherapy

    Página :S17

    P. Pizzi, E. Bley, O. Castillo, R. Gomez, A. Bulboa, F. Balbontin

    Esquema Esquema
  • ·SCHU-45: Photoselective Vaporization of the Prostate: Analysis of a Series with More Than One Year of Follow-Up

    Página :S17

    C. Ramos, J.M. Campero, A. Hinrichs, N. Zambrano, R. Rosenfeld

    Esquema Esquema
  • ·SCHU-46: Laser Vaporization Versus Prostate Transurethral Resection For the Treatment of Prostatic Hyperplasia: Comparison of Their Clinical Effectiveness

    Página :S18

    T. Olmedo, M.A. Cuevas, M. Olea, J.C. Frías, F. Marchant, P. Díaz, E. Solís, C. Palma, R. Valdevenito, O. Storme, F. Osorio, J. Benavides

    Esquema Esquema
  • ·SCHU-47: A Retrospective Study of 80 Patients with Organ-Confined Prostate Cancer Treated with Brachytherapy

    Página :S18

    F. Balbontin, O. Castillo, R. Gomez, P. Pizzi

    Esquema Esquema
  • ·SCHU-48: Impact of Body Mass Index in Patients Undergoing Transrectal Biopsy for Prostate Cancer Screening

    Página :S18

    C. Acevedo, C. Huidobro, J. Cabezas, J. Fullá, M. Varas, V. Galleguillos, B. Huidobro

    Esquema Esquema
  • ·SCHU-49: Electrochemical Ablation of the Prostate: A Feasibility Study for the Treatment of Prostate Cancer and Benign Prostatic Hyperplasia

    Página :S19

    J. Cabezas, C. Huidobro, T. Larson, B. Fruland, C. Acevedo, F. Marchant, C. Palma, M. Olea, D. Reyes, O. Storme

    Esquema Esquema
  • ·SCHU-50: Antegrade Endopyelotomy in Supine Position for Ureteropielic Junction Obstruction in an HIV(+) Patient

    Página :S19

    B. Silva, F. Vargas, A. Vidal

    Esquema Esquema
  • ·SCHU-51: Percutaneous Nephrolithotomy in Supine Position with a Dilator Ballon

    Página :S20

    B. Silva, F. Vargas, A. Vidal

    Esquema Esquema
  • ·SCHU-52: Laparoscopic Resection of a Bladder Tumor: Combined Endoscopic and Laparoscopic Approach

    Página :S20

    H. Bermudez, O. Storme, J. Flores, C. Stein, R. Lyng, P. Bernier

    Esquema Esquema

• SIU World Pediatric Uro-Oncology Update

  • ·PED-01: Recovery Factors Affecting Discard of Small Pediatric Donor Kidneys

    Página :S23

    S. Fujita, T. Iida, J. Magliocca, R. Kim, I. Zendejas, A. Hemming, R. Howard, L. Kayler

    Esquema Esquema
  • ·PED-02: Does Renal Scarring Affect the Spontaneous Resolution and Breakthrough Infection in Children with Vesicoureteral Reflux (VUR)?

    Página :S23

    J. Park, H. Shin, H. Chung, K. Lee

    Esquema Esquema
  • ·PED-03: Long-Term Functional Results of Continent Iieocecal Urinary Reservoir in Exstrophy-Epispadias Complex

    Página :S23

    I. Bassiouny, A. Aalcadhi, A. Ibrahim

    Esquema Esquema
  • ·PED-04: Sutureless Circumcision

    Página :S23

    S. Asgari, M. Mansur Ghanaie, S. Falahatkar, H. Neiroomand, S. Asgari, M. Abarpour, S. Emadi

    Esquema Esquema
  • ·PED-05: Endoscopic Urethral Anastomosis to Disrupted Bladder After Pelvic Fracture in Children

    Página :S24

    M. Wishahi, A. Aziz, M. Ali, A. Salah, T. Sweelim

    Esquema Esquema
  • ·PED-06: Screening for Uro-Genital Congenital Malformations

    Página :S24

    V. Stanca, O. Metes, N. Crisan, I. Coman

    Esquema Esquema
  • ·PED-07: Demucosed Colocystoplasty Preserving the Urothelium: Our Experience

    Página :S24

    E. Arias, R. Yañez

    
  • ·PED-08: Unsuspected Gonadoblastoma: The Role of Laparoscopic Gonadectomy in Disorders of Sexual Differentiation

    Página :S24

    J. Ortenberg, M. Koyle

    Esquema Esquema
  • ·PED-09: Treatment of Non-metastatic Rhabdomyosarcoma of the Prostate in Childhood and Adolescence: The Role of Surgery

    Página :S25

    J. Lopez, V. Durán, C. Burek, J. Corbetta, M. Dávila, A. Rosé, R. Dingevan, C. Sager, E. Perazzo

    
  • ·PED-10: Pheocromocytoma in Children: Is the Laparoscopic Adrenalectomy Safe?

    Página :S25

    F.T. Dénes, R.F. Coelho, M. Machado, B.B. Mendonça, M. Srougi

    
  • ·PED-11: Embryonal Rhabdomyosarcoma of the Urachus Presenting as Acute Abdomen: A Case Report

    Página :S25

    N. Letelier, A.M. Castillo, R. Zubieta, P.J. López, R. Gana, G. Retamal

    
  • ·PED-12: Testis Sparing Surgery for Intratesticular Masses

    Página :S25

    J.M. Escala, F. Castro, G. Retamal, N. Letelier, R. Zubieta, P.J. Lopez, R. Gana

    Esquema Esquema

• Podium Sessions

  • ·POD-1.01: Trifecta Outcomes in Preoperatively Potent Men After Nerve Sparing Robotic Laparoscopic Radical Prostatectomy

    Página :S29

    M. Orvieto, S. Shikanov, K. Zorn, A. Shalhav, G. Zagaja

    Esquema Esquema
  • ·POD-1.02: The Impact of Warm Ischemia Time on Perioperative Outcomes and Creatinine Clearance in Patients Undergoing Laparoscopic Partial Nephrectomy

    Página :S29

    M. Orvieto, A. Bernstein, M. Katz, M. Eng, K. Zorn, A. Shalhav

    Esquema Esquema
  • ·POD-1.03: The Adjustable Male Sling for Stress Urinary Incontinence After Prostate Surgery

    Página :S29

    B. Schrier

    Esquema Esquema
  • ·POD-1.04: RFA and Cryoablation as Treatment for Small Renal Tumours: A Literature Study with Analysis of Complications and Short-Term Results

    Página :S30

    C. Van Haute, S. Joniau, H. Van Poppel

    Esquema Esquema
  • ·POD-1.05: Laparoscopic Adrenalectomy in Children: A Safe and Effective Procedure

    Página :S30

    P. Lobos, M. Ormaechea, M. Urquizo Lino, J. Moldes, F. deBadiola, E. Ruiz, M. Boer, C. Giuseppucci, M. Alarcon

    Esquema Esquema
  • ·POD-1.06: Laparoscopic Adrenalectomy for Malignant Adrenal Masses

    Página :S30

    R. Campos, O. Castillo, I. Vidal, A. Foneron, M. Feria, M. García, M. González

    Esquema Esquema
  • ·POD-1.07: International Multi-Center Evaluation of the Adjustable Continence Therapy (Proact™) for Male Post-prostatectomy Stress Urinary Incontinence

    Página :S31

    F. Trigo Rocha, P. Gilling, W. Hubner, E. Kocjancic

    Esquema Esquema
  • ·POD-1.08: Suprapubic Cystostomy at Time of Vattikuti Institute Prostatectomy (VIP): Preliminary Results with Catheter Removal on Postoperative Day 1

    Página :S31

    L. Krane, R. Laungani, N. Patil, M. Bhandari, C. Rogers, H. Stricker, J. Peabody, M. Menon

    Esquema Esquema
  • ·POD-1.09: Advantages of Hand-Assisted Laparoscopic Partial Nephrectomy

    Página :S31

    C. Teigland, W. DeVoe, W. Hope, J. Norton, K. Kercher

    Esquema Esquema
  • ·POD-1.10: Radiofrequency Ablation of Small Renal Masses: A Multicenter Analysis of Intermediate Term Results of 56 Tumors in 49 Patients

    Página :S32

    S. Joniau, T. Tailly, L. Goeman, R. Oyen, H. Van Poppel

    Esquema Esquema
  • ·POD-1.11: Maximizing Console Surgeon Independence During Robotic Kidney Surgery by Utilizing the 4th Arm and TilePro

    Página :S32

    A. Bhandari, R. Laungani, R. Boris, L. Krane, D. Eun, A. Shrivastava, M. Menon, C. Rogers

    Esquema Esquema
  • ·POD-2.01: Partial and Total Penectomy for Patients with Squamous Cell Carcinoma of the Penis: A Single Institute Experience

    Página :S33

    Y. Thyavihally, H. Tongaonkar

    Esquema Esquema
  • ·POD-2.02: Management of Germ Cell Tumors in Undescended Testis: A Single Institute Series

    Página :S33

    Y. Thyavihally, M. Sengar, U. Mahanthshetty, H. Tongaonkar

    Esquema Esquema
  • ·POD-2.03: Penile Cancer: Results From 380 Cases Treated by Surgery

    Página :S33

    A. Rempelakos, A. Papas, T. Arvanitakis, E. Koutsiaris, A. Marketakis, J. Papazoglou, A. Thanos

    Esquema Esquema
  • ·POD-2.04: Diagnosis of Human Papillomavirus (HPV): Infection of Male Genital Skin and Mucosa

    Página :S34

    L. Walczak, S. Dutkiewicz, S. Majewski, S. Jabloñska, A. Witeska

    Esquema Esquema
  • ·POD-2.05: Preservation of Erectile Function After Penile Cancer Radical Surgery

    Página :S34

    E. Austoni, F. Colombo, A. Guarneri, A. Cazzaniga

    Esquema Esquema
  • ·POD-2.06: Organ-Preserving Surgery for Penile Cancer

    Página :S34

    M. Albersen, S. Joniau, H. Van Poppel

    Esquema Esquema
  • ·POD-2.07: Methylation in Testicular Cancer

    Página :S35

    I. Vidal, A. Velasco, E. Riquelme, A. Majerson, L. Frederick, O. Castillo, G. Mendez, F. Balbontin, R. Cabello, A. Foneron

    Esquema Esquema
  • ·POD-2.08: Chemotherapy for Testis Conservation in Patients with Germ Cell Cancer (GCC): Is It Safe and Could Combination with Tumour Enucleation Increase the Frequency of Success?

    Página :S35

    T. Oliver, J. Shamash, T. Powles, R. Reznek, D. Badenoch, V. Nargund

    Esquema Esquema
  • ·POD-2.09: Long-term Follow-up in Patients with Non-germinal Testicular Tumors

    Página :S36

    A. Foneron, O. Castillo, A. Velasco, I. Vidal, R. Campos, M. Feria, F. Balbontin, R. Cabello

    Esquema Esquema
  • ·POD-2.10: Incidence of Retroperitoneal Teratoma in Patients with Non-seminomatous Germ Cell Cancer of the Testis

    Página :S36

    J. Dominguez, O. Del Real, R. Pinochet, J. Cabello, P. Gonzalez

    Esquema Esquema
  • ·POD-2.11: Brachytherapy for Squamous Carcinoma of the Penis: A Penile Conserving Option

    Página :S36

    J. Crook, C. Ma, B. Esche, L. Grimard, J. Jezioranski

    Esquema Esquema
  • ·POD-3.01: Intermittent Androgen Suppression Delayed the Time to PSA Failure in Locally-Advanced and Metastatic Prostate Cancer Compared with Continuous Androgen Suppression in Japan

    Página :S37

    N. Sato, H. Nakatsu, K. Akakura, H. Suzuki, T. Ichikawa

    Esquema Esquema  
  • ·POD-3.02: Outcome of Patients with Positive Surgical Margins Following Radical Prostatectomy Treated with Adjuvant Hormonal and Radiation vs. Salvage Therapy: Selection Criteria Identified

    Página :S37

    M. Bulbul, N. Bou Diab, Y. El Hout, A. Houjeij, O. Darwish, A. Tawil, F. Geara

    Esquema Esquema
  • ·POD-3.03: Evaluation of a New Incisionless Technique for Surgical Androgen Deprivation in Men with Prostate Cancer: A Prospective Randomized Comparison of Bilateral Orchidectomy and Clamp Ablation of the Testes

    Página :S38

    A. Zarrabi, C. Heyns

    Esquema Esquema
  • ·POD-3.04: Early Salvage Radiotherapy After Radical Prostatectomy at a Low PSA Level

    Página :S38

    L. Jarolim, S. Vesely, I. Kawaciuk, P. Dusek, L. Hyrsl, M. Schmidt

    Esquema Esquema  
  • ·POD-3.05: N-telopeptide of Type I Collagen (NTX) Response to Zoledronic Acid in Patients with Bone Metastases from Prostate Cancer

    Página :S39

    F. Saad, R. Cook, R. Coleman, A. Lipton

    Esquema Esquema
  • ·POD-3.06: How Frequent are Metabolic Syndrome and Cardiovascular Risk Factors in Patients Receiving Long-term Hormonal Therapy for Prostate Cancer Treatment?

    Página :S39

    M. Tobias-Machado, P. Maia, J. L. Silva, E. G. Silva, M. L. Wroclawski, E. Wroclawski

    Esquema Esquema
  • ·POD-3.07: An Open-Label, Phase II Trial of 250mg Gefitinib (Iressa) in Prostate Cancer Patients with Early Biochemical Failure Post-prostatectomy

    Página :S39

    L. Klotz, A. Aprikian, N. Fleshner, J. Chin, M. Gleave, M. Zarenda

    Esquema Esquema
  • ·POD-4.01: Role of TPS, TPA and PSA in Treatment Monitoring of Prostate Carcinoma

    Página :S40

    M. Claessens, H. Van Poppel, H. Goike, S. Joniau

    Esquema Esquema
  • ·POD-4.02: Iodine 125 Prostate Brachytherapy: 9-Year Experience with Over 1000 Patients

    Página :S40

    J. Crook, I. Yeung, J. Borg, M. McLean, G. Lockwood

    Esquema Esquema
  • ·POD-4.03: Complications of Radical Prostatectomy: Analysis of Predictors

    Página :S40

    F. Rabbani, K. Touijer, K. Vora, J. Eastham, B. Guillonneau, P. Scardino

    Esquema Esquema
  • ·POD-4.04: A Modified Vesicourethral Anastomosis Technique in Radical Retropubic Prostatectomy and Its Impact on Continence

    Página :S41

    S. Önol, F. Önol, B. Arslan, Y. Ilbey, E. Ozbek

    Esquema Esquema
  • ·POD-4.05: Patient Safety Events Associated with Open and Laparoscopic Radical Retropubic Prostatectomy

    Página :S41

    K. Chrouser, D. Chang

    Esquema Esquema
  • ·POD-4.06: Evaluation of Cystographic Leak in Patients Undergoing Robotic Prostatectomy

    Página :S41

    N. Patil, K. Javed, L. Krane, M. Bhandari, T. Williams, M. Menon

    Esquema Esquema
  • ·POD-4.07: Radical Prostatectomy for PSA >20 and <100 ng/ml

    Página :S42

    S. Joniau, P. Gontero, G. Marchioro, A. Tizzani, B. Frea, H. Van Poppel

    Esquema Esquema
  • ·POD-4.08: Racial Disparity Remains Associative with Advanced Prostate Cancer in late PSA-era: An Analysis of 2784 Radical Prostatectomies After 2000

    Página :S42

    D. Albala, J. Moul, K. Zorn, C. Robertson, F. Schroeck, S. Shikanov, G. Zagaja, A. Shalhav, L. Sun

    Esquema Esquema
  • ·POD-4.09: Accelerated Continence Recovery After Robotic Prostatectomy Using Cornell Anatomic Reconstruction Technique: Experience of 1018 Patients

    Página :S43

    G. Tan, J. Jhaveri, S. Rao, R. Yadav, R. Leung, E. Vaughan, A. Tewari, G. Bartsch

    Esquema Esquema
  • ·POD-4.10: Phase II Study of Treatment with 5-Alpha Reductase Inhibitors (5ARIs) in Low-Risk Prostate Cancer

    Página :S43

    Y. Fradet, M. Lodde, J. Levesque, F. Harel, L. Lacombe, T. Dujardin

    Esquema Esquema
  • ·POD-4.11: Extent of Lymphadenectomy and Biochemical Recurrence After Radical Prostatectomy: A Multicenter Study

    Página :S43

    Y. Fradet, M. Lodde, F. Harel, H. Hovington, L. Lacombe, D. Wood, M. Harris

    Esquema Esquema
  • ·POD-4.12: Stratification of Age and Gleason Grade as a Model for Selection of Optimal Candidates for Definitive Therapy of Localized Prostate Cancer

    Página :S44

    C. Robertson, D. Albala, L. Sun, F. Schroeck, C. Donatucci, J. Smith, J. Moul

    Esquema Esquema
  • ·POD-5.01: Seladin-1 in the Prostate: A Potential Protector Against Cancer Progression

    Página :S44

    M. Guan, M. Battista, V. Robert, C. Roberge, A. Doueik, N. Gallo-Payet, R. Sabbagh

    Esquema Esquema
  • ·POD-5.02: Clinical Application of Chromosome 8q24 SNP 's in Prostate Cancer Detection

    Página :S44

    S. Punnen, W. Zhang, L. Klotz, J. Trachtenberg, M. Kattan, S. Narod, R. Nam

    Esquema Esquema
  • ·POD-5.03: Hyperinsulinaemia is a Prospective Risk Factor for Developing Prostate Cancer

    Página :S45

    J. Hammarsten, T. Berggren, J. Damber, R. Peeker, D. Mellström, B. Högstedt

    Esquema Esquema
  • ·POD-5.04: A Prospective, Randomised Study Comparing the Vienna Nomogram to an 8-Core Standard TRUS Guided Prostate Biopsy Protocol

    Página :S45

    J. Stander, A. Lecuona, C. Heyns, A. Naidoo

    Esquema Esquema
  • ·POD-5.05: Prostate-Targeted Biopsy Navigated by Real-time Virtual Sonography Acquired from MRI Volume Data

    Página :S45

    S. Ishikawa, T. Miyagawa, T. Kimura, T. Suetomi, M. Tsutsumi, T. Irie, M. Kondoh, O. Arai, T. Mitake

    Esquema Esquema
  • ·POD-5.06: Defining Men at Increased Future Risk of Prostate Cancer: Evidence from a Population-Based Screening Cohort

    Página :S46

    F. Schröder, M. Roobol, G. Andriole, N. Fleshner

    Esquema Esquema
  • ·POD-5.07: Radical Prostatectomy Findings in Patients Considered Potential Candidates for Active Surveillance

    Página :S47

    J. Davis, J. Kim, J. Ward, H. Nakanishi, X. Wang, R. Babaian, P. Troncoso

    Esquema Esquema
  • ·POD-5.08: Active Surveillance for Clinically-Localized Prostate Cancer at a High Volume Tertiary Referral Center

    Página :S47

    J. Davis, P. Troncoso, J. Ward, R. Babaian, C. Pettaway, L. Pisters, D. Kuban, C. Logothetis, J. Kim, V. Brown

    Esquema Esquema
  • ·POD-5.09: The Effect of Inflammation in the Prostate Gland on Tissue Molecular Markers for Prostate Cancer in Arab Men

    Página :S47

    E. Kehinde, M. Al-Maghrebi, J. Anim, J. John, R. Eapen, A. Prasad

    Esquema Esquema
  • ·POD-5.10: Endothelin-1 Immunostaining as a Prognostic Marker of pT3a Adenocarcinoma on Prostate Biopsies

    Página :S48

    J. Menard, T. Perez, K. Joseph, P. Birembaut, F. Staerman

    Esquema Esquema
  • ·POD-5.11: Predictors and Pathological Features of Prostate Cancer on Repeat Biopsy with High-grade Prostatic Intraepithelial Neoplasia (HPIN) and/or Atypical Small Acinar Proliferation (ASAP)

    Página :S48

    J. Chin, D. Lim, M. Abdelhady, D. Downey, J. Izawa

    Esquema Esquema
  • ·POD-5.12: Pathological Disease Progression on Repeat Transrectal Biopsy in a Contemporary Active Surveillance Cohort of Prostate Cancer Patients: Looking at Disease Progression with a 5-year Follow-Up

    Página :S48

    A. Feifer, M. Al-Otaibi, K. Sircar, L. Begin, W. Kassouf, A. Aprikian, S. Tanguay

    Esquema Esquema
  • ·POD-5.13: Nutritional Elements Affecting Prostate Cancer Progression of Patients on Active Surveillance

    Página :S49

    L. Campeau, P. Ross, P. Violette, S. Mahmud, S. Jeyaganth, R. Repa-Fortier, S. Tanguay, A. Aprikian

    Esquema Esquema
  • ·POD-5.14: A Multidimensional Scale for Assessment of Sexuality After Radical Prostatectomy for Prostate Cancer

    Página :S49

    R. Messaoudi, J. Menard, F. Staerman

    Esquema Esquema
  • ·POD-6.01: A Retrospective Review of Renal Ablative Therapies for Renal Masses: Clinical Outcomes

    Página :S50

    M. Dhar, R. Kozak, J. Amann, L. Nott, S. Pautler

    Esquema Esquema
  • ·POD-6.02: A Multicenter, Randomized, Phase III Trial of a Novel, Autologous, Therapeutic Vaccine (Vitespen) vs. Observation as Adjuvant Therapy in Patients at High Risk of Recurrence After Nephrectomy for Renal Cell Carcinoma

    Página :S50

    S. Tanguay, C. Wood, R. Bukowski, P. Champagne, P. Srivastava, B. Escudier, L. Lacombe

    Esquema Esquema
  • ·POD-6.03: The Comparison of Efficacy and Side Effects Between M-VAC and GC Chemotherapy in Advanced and Metastatic Urothelial Carcinoma Patients with Good Performance Status

    Página :S50

    J. Chung, H. Kwak, S. Jung

    Esquema Esquema
  • ·POD-6.04: Evaluation of Sorafenib Treatment in Metastatic Renal Cell Carcinoma with Positron Emission Tomography

    Página :S51

    D. Lyrdal, M. Boijsen, M. Suurküla, S. Lundstam, U. Stierner

    Esquema Esquema
  • ·POD-6.05: Treatment of Metastatic Renal Cell Carcinoma by Peginterferon Alfa-2b

    Página :S51

    S. Lundstam, D. Lyrdal, U. Stierner

    Esquema Esquema
  • ·POD-6.06: Robotic Nephrectomy for Treatment of Benign and Malignant Disease

    Página :S52

    R. Laungani, L. Krane, A. Bhandari, A. Shrivastava, M. Menon, C. Rogers

    Esquema Esquema
  • ·POD-6.07: Surgical Morbidity Associated with Administration of Targeted Molecular Therapies Prior to Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma

    Página :S52

    C. Wood, V. Margulis, S. Matin, P. Tamboli, D. Swanson

    Esquema Esquema
  • ·POD-6.08: Positive Margin After Nephron Sparing Surgery: Our Experience

    Página :S52

    E. Garcı́a-Cruz, L. Peri, M. Ribal, R. Álvarez-Vijande, R. Gutiérrez Del Pozo, A. Alcaraz

    Esquema Esquema
  • ·POD-6.09: Retroperitoneal Lymph Node Recurrence in Patients with Transitional Cell Carcinoma of Upper Urinary Tract

    Página :S52

    D. Kim, Y. Lee, K. Cho, W. Ham, S. Park, Y. Choi, S. Hong

    Esquema Esquema
  • ·POD-6.10: Robotic Partial Nephrectomy: A Multi-institutional Analysis

    Página :S53

    C. Rogers, M. Menon, E. Weise, M. Gettman, I. Frank, D. Shephard, H. Abrahams, J. Green, D. Savatta, S. Bhayani

    Esquema Esquema
  • ·POD-6.11: Computerized Tomography Measurement of Visceral Adiposity Predicts Plasma Adiponectin Levels and Presence of Metastatic Disease in Patients with Clear Cell Renal Cell Carcinoma

    Página :S54

    A. Kapoor, S. Chatterjee, N. Kleinmann, J. Pinthus

    Esquema Esquema
  • ·POD-6.12: Progression Free Survival in Patients with Metastatic and Recurrent Renal Cancer Treated with Sorafenib: Single Center Experience

    Página :S54

    A. Kapoor, S. Chatterjee, J. Pinthus, S. Hotte, N. Kleinmann

    Esquema Esquema
  • ·POD-6.13: Serum Amyloid Alpha 1: Potential Marker for Renal Cell Carcinomas?

    Página :S54

    K. Junker, C. Georgi, M. Walter, R. Pilchowski, T. Steiner, J. Schubert

    Esquema Esquema
  • ·POD-7.01: Laparoscopic Radical Cystectomy: Our Results After 85 Consecutive Patients

    Página :S55

    O. Castillo, I. Vidal, A. Foneron, R. Campos, M. Feria

    Esquema Esquema
  • ·POD-7.02: Neobladder Reconstruction After Extraperitoneal Ultrasound Assisted Radical Cystectomy: A Report on an Easy Procedure

    Página :S55

    E. Austoni, F. Colombo, A. Guarneri, A. Cazzaniga

    Esquema Esquema
  • ·POD-7.03: Micropapillary Bladder Cancer: Comparison of Outcomes with Up-front Cystectomy and Neoadjuvant Chemotherapy

    Página :S55

    A. Kamat, E. Chiong, J. Taylor, A. Siefker-Radtke, H. Grossman, C. Dinney

    Esquema Esquema
  • ·POD-7.04: The Role for Radical Cystoprostatectomy in Patients with Clinical T4b Bladder Cancer

    Página :S56

    A. Kamat, P. Black, C. Dinney, H. Grossman, A. Siefker-Radtke

    Esquema Esquema
  • ·POD-7.05: The Role of Prostatic Urethral Biopsy in Counseling Patients Regarding Orthotopic Neobladder Reconstruction

    Página :S56

    A. Kamat, W. Kassouf, C. Dinney, H. Grossman, P. Spiess

    Esquema Esquema
  • ·POD-7.07: Can We Determine the Result of Repeat Transurethral Resection in Patients with Newly Diagnosed Non-muscle Invasive Bladder Cancer?

    Página :S56

    R. Tomaskin, B. Elias, K. Machalekova, P. Slavik, I. Sopilko, J. Kliment

    Esquema Esquema
  • ·POD-7.08: Intravesical Mitomycin C Versus Bacillus Calmette-Guérin for Non-muscle Invasive Bladder Cancer: An Individual Patient Data Meta-analysis of Randomized Studies

    Página :S57

    P. Malmström, R. Sylvester, Meta-Analysis Study Group

    Esquema Esquema
  • ·POD-7.09: Combination of Cell Cycle Regulating Bio-markers Improves Prognosis in Patients with Organ Confined Urothelial Cancer at Radical Cystectomy

    Página :S57

    A. Sagalowsky, S. Shariat, P. Karakiewicz, Y. Fradet, R. Ashfaq, J. Stein, P. Bastian, M. Nielsen, N. Suardi, F. Montorsi, S. Groshen, S. Mueller, J. Rigaud, L. Heukamp, G. Netto, S. Lerner, R. Cote, Y. Lotan

    Esquema Esquema
  • ·POD-7.10: Blocking AKT Pathway Inhibits X-IAP and Enhances Taxol-induced Apoptosis of Bladder Cancer

    Página :S57

    C. Yang, Y. Ou, S. Yuan

    Esquema Esquema
  • ·POD-7.11: The Effect of the Patient 's Age on Bladder Cancer Immunotherapy Response and Adverse Events: MCC Experience

    Página :S58

    F. Charette, A. Morales, Z. Cohen, K. Darbyson

    Esquema Esquema
  • ·POD-7.12: Impact of Age on the Ability of Mycobacterial Cell Wall-DNA Complex (MCC) to Induce Urinary Biological Response Markers in Patients with Non-muscle Invasive Bladder Cancer

    Página :S58

    M. Filion, N. Phillips, A. Morales, B. Filion, K. Darbyson, F. Charette

    Esquema Esquema
  • ·POD-7.13: Robotic-Assisted Laparoscopic Surgery for Invasive Bladder Cancer: Can the Lymph Node Dissection Match the Benchmarks of Open Surgery?

    Página :S58

    J. Davis, A. Kamat, H. Grossman, K. Gaston, C. Dinney

    Esquema Esquema

• Moderated Poster Sessions

  • ·MP-1.01: The Role of Hyperinsulinemia and Insulin Resistance in Prostate Growth: Are They Truly Associated with Prostatic Enlargement?

    Página :S60

    Y. Lee, S. Hong, K. Cho, D. Kim, W. Ham, S. Park, Y. Choi, S. Kwon

    Esquema Esquema
  • ·MP-1.02: CD133, Ki-67 and AR Cell Marker in the Mouse Prostate Gland During Development and Growth

    Página :S60

    C. Sanchez, J. Philimon, I. Silva, J. Inostroza, R. Vallejos, P. Quiroz, O. Espinoza-Navarro, H. Rodriguez, G. Venegas

    Esquema Esquema
  • ·MP-1.03: The Minisatellites Polymorphisms Within hTERT Gene Region with Cancer Predisposition

    Página :S60

    S. Jung, J. Chung

    Esquema Esquema
  • ·MP-1.04: Aqueous Extract of Phellinus linteus Induces Apoptosis in Human DU-145 Prostate Cancer Cells

    Página :S61

    H. Jung, T. Kim, S. Lee, S. Yoon, J. Yun, K. Kim

    Esquema Esquema
  • ·MP-1.05: Prognostic Value of Growth Factors Production in Prostate Cancer Patients

    Página :S61

    B. Alekseev, P. Shegay, O. Popova, T. Danilova, I. Rusakov, G. Frank, Y. Andreeva, A. Ivanov

    Esquema Esquema
  • ·MP-1.06: Is Diabetes Mellitus Associated with Aggressive Characteristics in Prostate Cancer?

    Página :S62

    L. Krane, N. Patil, E. Kheterpal, M. Bhandari, J. Peabody, M. Menon

    Esquema Esquema
  • ·MP-1.07: Association Between Toll-like Receptor 4 Polymorphisms and Prostate Cancer in Korean Men

    Página :S62

    G. Lee, D. Kim, C. Kim, H. Kim, D. Lee, H. Lee, W. Ko, J. Song

    Esquema Esquema
  • ·MP-1.08: Multicenter Phase III Randomized Controlled Trial of Toremifene to Prevent Fractures and Other Adverse Effects of Androgen Deprivation Therapy in Men with Prostate Cancer

    Página :S62

    M. Steiner, G. Barnette, M. Hancock, R. Morton, D. Rodriguez

    Esquema Esquema
  • ·MP-1.09: Metabolic Changes in Androgen Deprivation Therapy for Prostate Cancer: Chlormadinone Acetate May Have a Favorable Effect on Lipid Metabolism

    Página :S63

    H. Sakai, T. Igawa, H. Kanetake, M. Furukawa, M. Hayashi, T. Sakuragi, Y. Kusaba, H. Hakariya

    Esquema Esquema
  • ·MP-1.10: Salvage Radiotherapy After Open Radical Retropubic Prostatectomy: Our 14 Year Experience

    Página :S63

    R. Cetti, P. Carter

    Esquema Esquema
  • ·MP-1.11: Functional and Oncological Outcome of Locally-Advanced Prostate Cancer Primarily Treated by Radical Prostatectomy

    Página :S63

    A. Hinev, S. Paunov, P. Chankov, D. Anakievski, S. Dyakov, R. Raikov, M. Panchelieva, L. Marinova

    Esquema Esquema
  • ·MP-1.12: Circulating LDH Value in HRPC Patients After Ten Cycles of Chemotherapy: A Marker of Soft Tissue Lesions

    Página :S64

    P. Bouffette, S. Buhic, Z. Kusic, I. Kraljic, M. Tarle

    Esquema Esquema
  • ·MP-1.13: Sub-epididymal Orchidectomy for Metastatic Carcinoma Prostate: A Point of Technique

    Página :S64

    S. Bapat, B. Kashyapi, A. Padhye, P. Yadav, P. Mahajan, A. Bhave, Y. Sovani, Y. Kshirsagar

    Esquema Esquema
  • ·MP-1.14: Expression of HER-2 in Disseminated Tumor Cells in Bone Marrow of Patients with Prostate Cancer is Associated with Resistance to Androgen Blockage but not DES

    Página :S65

    N. Murray, L. Badinez

    Esquema Esquema
  • ·MP-1.15: Predictive Factors for Failing to Achieve a Nadir Prostate Specific Antigen of 1.0ng/ml or Less After Combined Androgen Blockade

    Página :S65

    S. Park, C. Sul, H. Rhew, J. Rim

    Esquema Esquema
  • ·MP-1.16: HER2 Protein: Is It a Potential Predictor of Locally-Advanced Prostate Carcinoma?

    Página :S66

    S. Stavridis, L. Lekovski, S. Dohcev, S. Banev, N. Orovcanec, A. Stavridis

    Esquema Esquema
  • ·MP-2.01: Surgical Apgar: Perioperative Risk Assessment for Radical Cystecomy

    Página :S66

    M. Ferreira, S. Prasad, M. Prasad, J. Hu, J. Richie, S. Sawh

    Esquema Esquema
  • ·MP-2.02: Identification of Novel MicroRNA Targets Based on MicroRNA Signature in Bladder Cancer

    Página :S66

    H. Enokida, I. Takahiro, S. Naohiko, N. Masayuki

    Esquema Esquema
  • ·MP-2.03: Continent Orthotopic Sigmoid Neobladder Urinary Diversion After Radical Cystectomy: Evolution of Technique and Long-Term Data

    Página :S67

    I. Khalaf

    Esquema Esquema
  • ·MP-2.04: Broadhesive Coated Nanoparticles Loaded with Mitomycin C for the Effective Chemotherapy of Superficial Bladder Cancer

    Página :S67

    N. Mungan, C. Sarisozen, L. Dogan, G. Esendagli, E. Bilensoy

    Esquema Esquema
  • ·MP-2.05: Pathologic Pattern of Invasive Bladder Carcinoma: Impact of Bilharziasis

    Página :S68

    I. Khalaf, E. Elmallah, I. Elsotouhi, M. Mahmoud

    Esquema Esquema
  • ·MP-2.06: Cytokine Levels in Patients of Transitional Cell Carcinoma Urinary Bladder

    Página :S68

    A. Seth, P. Singh, A. Satyam, A. Sharma, N. Gupta

    Esquema Esquema
  • ·MP-2.07: The Antiproliferative Activity of MCC (Mycobacterial Cell Wall-DNA Complex) is Independent of p53 Mutational Status, p21 Gene Polymorphisms, Aneuploidy of Chromosomes 3, 7 and 17, and Loss of 9p21 Locus in Bladder Cancer Cell Lines

    Página :S68

    K. Lainesse, S. Ménard, D. Ke, C. Cassas, A. Prada, Y. Fan, N. Phillips, M. Filion

    Esquema Esquema
  • ·MP-2.08: Anti-tumor Effect on Bladder Cancer with Conditionally Replicating Oncolytic Viruses Derived from Herpes Simplex Viruses

    Página :S69

    Y. Cho, K. Joo, H. Park, C. Kwon, J. Choi, W. Lee, H. Kim, X. Zhang, S. Lerner

    Esquema Esquema
  • ·MP-2.09: Detection of Circulating Tumor Cells in the Blood of Patients with Muscle Invasive Bladder Cancer Prior to Radical Cystectomy

    Página :S69

    T. Guzzo, T. Bivalacqua, L. Sokoll, M. Schoenberg

    Esquema Esquema
  • ·MP-2.10: Identification of Aberrant Promoter Methylation of TBX5, PENK and T in Detection of Urothelial Carcinoma in Exfoliated Urine Cells

    Página :S69

    C. Sul, D. Koo, K. Kim, J. Shin, Y. Na, H. Kim, J. Lim, S. An, Y. Moon, Y. Kim, Y. Hyun, S. Ki Hak

    Esquema Esquema
  • ·MP-2.11: Prognostic Significance of Cyclooxygenase-2 (COX-2) Immunoreactivity in Inflammatory Stromal Cells in COX-2 Positive Urothelial Bladder Tumors

    Página :S70

    I. Mokos, J. Jakic-Razumovic, Z. Kastelan

    Esquema Esquema
  • ·MP-2.12: Transurethral Layer-Section of Muscle Invasive Bladder Cancer: Accurate T Staging and Bladder Preservation in a Selected T2 Bladder Cancer

    Página :S70

    Y. Choi, W. Kim, W. Ham, K. Cho, N. Cho, H. Lee, J. Lee, H. Ju

    Esquema Esquema
  • ·MP-2.13: The Efficacy of Urine Cytology, Nuclear Matrix Protein (NMP) 22 Fluorescence In Situ Hybridization (FISH) in Bladder Cancer

    Página :S70

    Y. Choi, W. Kim, W. Ham, H. Yu, H. Lee, J. Lee

    Esquema Esquema
  • ·MP-2.14: Underlying Malignancy Is the Most Common Cause of Urinary Retention in Women in a Developing African Country

    Página :S71

    C. Van Der Walt, S. Van Vuuren, C. Heyns

    Esquema Esquema
  • ·MP-2.15: Long-term Outcomes of Sigmoid Neobladder After Radical Cystectomy in an Indian Population: A Single Centre Experience

    Página :S71

    A. Seth, S. Panda, A. Kumar, P. Singh, A. Hemal, N. Gupta

    Esquema Esquema
  • ·MP-2.16: Clinical Outcome Following Prostatic Capsule and Seminal Sparing Cystectomy for Bladder Cancer in 25 Men

    Página :S72

    A. Thorstenson, C. O'Connor, R. Ahonen, M. Jonsson, H. Wijkström, O. Akre, A. Abolfazl Hosseini, P. Wiklund, L. Henningsohn

    Esquema Esquema
  • ·MP-2.17: Feasibility Study of Population-Based Screening for Bladder Cancer with Urinary Molecular Markers (BLUP): (www.blu-project.org)

    Página :S72

    M. Roobol, T. Zuiverloon, E. Zwarthoff, M. Busstra, C. Franken-Raab, C. Bangma

    Esquema Esquema
  • ·MP-2.18: Detection Rate of Malignancy in Patients with Lower Urinary Tract Symptoms Without Pyuria

    Página :S72

    H. Kim, P. Song, C. Hyun, K. Moon, H. Jung, T. Park

    Esquema Esquema
  • ·MP-2.19: Is Seminal Sparing Possible in Radical Cystectomy of Organ-Confined Bladder Cancer?

    Página :S73

    M. Navarro Genta, R. Tagle Alegría, J. Montes Miranda, R. Muranda, B. López, C. Barría

    Esquema Esquema
  • ·MP-2.20: Impact of Repeat Transurethral Resection on Recurrence of Primary Non-muscle Invasive Bladder Cancer

    Página :S73

    R. Tomaskin, B. Elias, K. Kajo, P. Slavik, I. Sopilko, J. Kliment

    Esquema Esquema
  • ·MP-2.21: BCG Intravesical Therapy in Bladder Tumor: 6 Week Course Versus Modified 6+3 Maintenance Therapy

    Página :S73

    J. Chung, S. Jung, S. Jung

    Esquema Esquema
  • ·MP-2.22: Low Recurrence Rate of Superficial Bladder Cancer: Is Re-Resection Necessary in Our Patients?

    Página :S74

    J. Dominguez, C. Parra, A. Walton, A. Dell'oro, P. Madrid, N. Moya, M. Leal

    Esquema Esquema
  • ·MP-2.23: Side Effects and Complications of Intravesical BCG Instillation in the Treatment of Non-Muscle Invasive Bladder Cancer

    Página :S74

    M. Orsolya, V. Osan, R. Boja, L. Schwartz, S. Nedelcu, C. Catarig, O. Golea, A. Chiujdea, O. Malau, D. Porav-Hodade, D. Muntoi, B. Uzun, B. Nagy, I. Lazar, S. Kovacs

    Esquema Esquema
  • ·MP-2.24: Bladder Cancer Incidence and Mortality Among Workers Exposed to Benzidine and 3,3-Dichlorobenzidine

    Página :S74

    M. Schoenberg, S. Brown, T. Guzzo, R. Alberts

    Esquema Esquema
  • ·MP-2.25: Initial Experience with Hexvix-Induced Fluorescence Blue Light Cystoscopy in Bladder Cancer Diagnosis

    Página :S75

    B. Geavlete, R. Multescu, D. Georgescu, P. Geavlete

    Esquema Esquema
  • ·MP-2.26: Urinary NMP22 BladderChek Test in Diagnosis of Bladder Cancer and Comparison with Urinary Cytology and Cystoscopic Biopsy

    Página :S75

    P. Sharma, B. Saraswat, A. Sharma

    Esquema Esquema
  • ·MP-2.27: Differences in Tumor Characteristics and Prognosis According to the Age in Patients with Newly Diagnosed Ta, T1 Transitional Cell Carcinoma of the Bladder

    Página :S75

    D. Kim, Y. Lee, K. Cho, S. Hong, Korean Urological Oncology Soc

    Esquema Esquema
  • ·MP-3.01: Learning Curve Improves Functional and Oncological Outcomes on Pure Laparoscopic Prostatectomy: Experience of a Reference Center in Brazil

    Página :S76

    M. Tobias-Machado, E. Wroclawski, E. Starling, R. Juliano, A. Tavares, J. Ii, E. Gomes, I. Youssef, F. Ferro, L. Da Costa

    Esquema Esquema
  • ·MP-3.02: Manual or Robotic High Intensity Focused Ultrasound (HIFU) in Prostate Cancer Therapy

    Página :S76

    S. Thueroff, C. Chaussy

    Esquema Esquema
  • ·MP-3.03: Transurethral Adenoma Resection Before High Intensity Focused Ultrasound (HIFU) Treatment of Prostate Cancer

    Página :S76

    C. Chaussy, S. Thueroff

    Esquema Esquema
  • ·MP-3.04: Robotic-Assisted Surgical Management of High-Risk Prostate Cancer

    Página :S77

    J. Davis

    Esquema Esquema
  • ·MP-3.05: Hypofractionated Accelerated Radiotherapy for Low-Risk Localized Prostate Cancer: The Further Follow-up of a Weekly Canadian Regimen

    Página :S77

    A. Loblaw, C. Tang, P. Cheung, A. Cesta, L. Holden, G. Morton, P. Basran, R. Tirona, M. Cardoso, G. Pang, S. Gardner

    Esquema Esquema
  • ·MP-3.06: Impact of Pelvic Lymph Node Dissection in High-Risk Prostate Cancer

    Página :S77

    A. Hinev, A. Klissarova, P. Ghenev, S. Paunov, B. Chaushev, P. Chankov, D. Anakievski, S. Dyakov, N. Kolev, T. Deliiski

    Esquema Esquema
  • ·MP-3.07: Clinical Experience with HIFU in Patients with Low-Risk Primary Prostate Cancer

    Página :S78

    G. Suarez, C. Garcia, R. Estrella, M. Ryan, J. Meseke

    Esquema Esquema
  • ·MP-3.08: Quality of Life After HIFU Treatment for Localized Prostate Cancer

    Página :S78

    P. Shestiperov, Y. Alyaev, A. Amosov, M. Chalyy, E. Bezrukov, G. Krupinov

    Esquema Esquema
  • ·MP-3.09: Robotic Radical Prostatectomy in Morbidly Obese Patients

    Página :S78

    R. Satyanarayana, L. Krane, M. Bhandari, M. Menon

    Esquema Esquema
  • ·MP-3.10: Perioperative and Pathological Outcomes in Obese Men: An Analysis of Robotic Assisted Laparoscopic Radical Prostatectomy

    Página :S79

    M. Ferreira, S. Sawh, F. Korkes, A. Berry, J. Hu

    Esquema Esquema
  • ·MP-3.11: Pathological Gleason Score Trends in Patients Undergoing Radical Prostatectomy

    Página :S79

    M. Orvieto, S. Shikanov, G. Zagaja, C. Brendler, A. Shalhav, K. Zorn

    Esquema Esquema
  • ·MP-3.12: Brachytherapy After 12 Years: Our Experience with 412 Cases with a Minimum Follow-Up of 12 Months

    Página :S79

    C. Cobreros, M. Borghi, L. Montes de Oca, E. Becher, V. Chernovilsky, A. Momesso, U. Iturralde

    Esquema Esquema
  • ·MP-3.13: Extraperitoneal Laparoscopic Radical Prostatectomy: Results of a Learning Curve After 310 Cases

    Página :S80

    O. Castillo, I. Vidal, R. Campos, A. Foneron, M. Feria

    Esquema Esquema
  • ·MP-3.14: Visually Directed High Intensity Focused Ultrasound: Techniques to Reduce Urethral Strictures

    Página :S80

    S. Scionti

    Esquema Esquema
  • ·MP-3.15: Patterns of Care for Radical Prostatectomy in the United States from 2003-2005

    Página :S80

    M. Ferreira, J. Hu, N. Hevelone, S. Lipsitz, M. Sanda, C. Earle, S. Sawh

    Esquema Esquema
  • ·MP-3.16: Impact of Prostate Weight on Surgical Outcomes of Robotic Assisted Laparoscopic Radical Prostatectomy

    Página :S81

    M. Ferreira, F. Korkes, S. Sawh, A. Berry, J. Hu

    Esquema Esquema
  • ·MP-3.17: Prostate Size is Associated with Surgical Difficulty but not Functional Outcome at One Year

    Página :S81

    J. Pettus, T. Masterson, A. Sokol, A. Cronin, C. Savage, J. Sandhu, J. Mulhall, P. Scardino, F. Rabbani

    Esquema Esquema
  • ·MP-3.18: Robotic Prostatectomy in Patients Over Seventy Years

    Página :S81

    N. Patil, L. Krane, N. Pokala, R. Satyanarayan, M. Bhandari, M. Menon

    Esquema Esquema
  • ·MP-3.19: Results of Extended and Radioisotope-Guided Pelvic Lymph Node Dissection in Prostate Cancer Patients

    Página :S82

    B. Alekseev, K. Nyushko, I. Rusakov, G. Frank, Y. Andreeva, E. Belova, N. Vorobyev, V. Polyakov

    Esquema Esquema
  • ·MP-3.20: Outcomes of High Intensity Focused Ultrasound (HIFU) in the Treatment of Localized Prostate Cancer

    Página :S82

    R. Sanseverino, O. Intilla, G. Napodano, A. Campitelli, U. Di Mauro, R. Angrisani

    Esquema Esquema
  • ·MP-3.21: Total Reconstruction:Technique for Precision Anastomosis and Continence Preservation

    Página :S83

    J. Jhaveri, G. Tan, S. Rao, R. Yadav, R. Leung, E. Vaughan, A. Tewari

    Esquema Esquema
  • ·MP-3.22: Gleason 6 Prostate Cancer in 1 or 2 Biopsy Cores Can Harbor More Aggressive Disease

    Página :S83

    M. Orvieto, M. Katz, S. Shikanov, G. Zagaja, A. Shalhav, K. Zorn

    Esquema Esquema
  • ·MP-4.01: Ablatherm HIFU in Organ-Confined Prostate Cancer: A Single Centre Canadian Experience

    Página :S83

    W. Orovan, M. Hassouna, E. Woods

    Esquema Esquema
  • ·MP-4.02: Prostate Cancer in Patients with PSA Values Between 2.5-4.0 ng/ml: Predictive Value of PSA Velocity

    Página :S84

    P. Geavlete, D. Georgescu, T. Jora, B. Geavlete

    Esquema Esquema
  • ·MP-4.03: P504S Expressing Prostate Cells in Blood of Healthy Men: A Possible Screening Test for Prostate Cancer

    Página :S84

    N. Murray, S. Santos

    Esquema Esquema
  • ·MP-4.04: Results in Patients with PSA of 2.5-4ng/ml and 4-10ng/ml Candidates for Prostate Biopsy

    Página :S84

    F. Gomez Veiga, J. Ponce, J. Pertega, E. Romero, P. Casas, J. Janeiro, A. Zarraonandia, I. Gómez Rodríguez, A. Alvarez, E. Martul, M. González-Martín

    Esquema Esquema
  • ·MP-4.05: Comparison of Robotic-Assisted Versus Retropubic Radical Prostatectomy Performed by a Single Surgeon

    Página :S85

    Y. Ou, C. Yang, C. Cheng

    Esquema Esquema
  • ·MP-4.06: Do the Epstein Criteria Continue to Predict Insignificant Prostate Cancer in the Modern Day Urological Setting?

    Página :S85

    R. Thanigasalam, K. Rasiah, P. Stricker, S. Sutherland, A. Haynes, S. Henshall

    Esquema Esquema
  • ·MP-4.07: Outcomes of Repeated Prostatic Biopsy Following HGPIN and ASAP on Initial Biopsy

    Página :S85

    R. Sanseverino, R. Angrisani, G. Napodano, U. Di Mauro, O. Intilla, A. Campitelli

    Esquema Esquema
  • ·MP-4.08: Value of DRE and PSA for Early Detection of Prostate Cancer During Prostate Awareness Campaign: Nationwide Study in Egypt

    Página :S86

    I. Khalaf, H. Aboelenin, M. El-Akkad, H. Rashwan, I. Shoukry, M. Zaaza, O. Abofarha, A. Elkassaby, A. Massoud, M. Abdelrahman

    Esquema Esquema
  • ·MP-4.09: TargetScan ®: A Novel Approach for Outpatient Prostate Biopsy with the Potential for Use as an Aid to Focal Prostate Therapy

    Página :S86

    P. Alphonse, N. Hood, S. Lyn, J. Foote, J. Bennett

    Esquema Esquema
  • ·MP-4.10: Pathological Characteristics of Prostate Adenocarcinomas Associated with High-Grade Prostatic Intraepithelial Neoplasia (HGPIN)

    Página :S87

    A. Bölükbasi, K. Bal, F. Þengül, A. Sezer, E. Aydinoglu, C. Öztürk, O. Bayir

    Esquema Esquema  
  • ·MP-4.11: Men with Prostate Cancer and Histological Evidence of Prostatitis Present with Acute Urinary Retention at an Earlier Stage of the Disease Compared to Those Without Prostatitis

    Página :S87

    C. Heyns, C. Van Der Walt, S. Van Vuuren

    Esquema Esquema
  • ·MP-4.12: Prevalence of Lower Urinary Tract Symptoms (LUTS) in Men with Adenocarcinoma of the Prostate, and Prospective Randomized Evaluation of the Alpha-adrenergic Blocker Doxazosin for the Treatment of LUTS in Men with Prostate Cancer

    Página :S88

    C. Heyns, J. Stander

    Esquema Esquema
  • ·MP-4.13: Apical Periprostatic Nerve Blockade Before Transrectal Ultrasound-Guided Prostate Biopsy: Are There Any Failure Factors? Our 254 Patients

    Página :S88

    S. Sallami, M. Chelif, S. Ben Rhouma, Y. Nouira, A. Horchani

    Esquema Esquema
  • ·MP-4.14: Evaluation of Two Prostate Cancer Risk Calculators in a Clinical Setting

    Página :S88

    V. Cavadas, F. Vila, L. Osório, M. Silva-Ramos, F. Marcelo

    Esquema Esquema
  • ·MP-4.15: Active surveillance in patients with low risk prostate cancer using a 20-core saturation biopsy technique

    Página :S89

    I. San Francisco, J. Bubley, M. Regan, W. DeWolf

    Esquema Esquema
  • ·MP-4.16: Real-Time Tissue Imaging of Prostate and Periprostatic Neural Tissue with Multiphoton Microscopy

    Página :S89

    R. Yadav, S. Mukherjee, F. Maxfield, J. Jhaveri, R. Leung, S. Rao, G. Tan, A. Tewari

    Esquema Esquema  
  • ·MP-4.17: Prostate Cancer is Significant Even in low PSA Ranges with a Family History

    Página :S90

    R. Satyanarayana, L. Krane, N. Patil, C. Rogers, M. Bhandari, M. Menon

    Esquema Esquema
  • ·MP-4.18: Novel Use of 3-Tesla Magnetic Resonance Microscopy in Staging Early Prostate Cancer: Congruency Between Radiologic Anatomy and Final Histopathology

    Página :S90

    S. Rao, D. Ballon, R. Yadav, R. Leung, J. Jhaveri, G. Tan, A. Tewari

    Esquema Esquema  
  • ·MP-4.19: Impact of Intraoperative Biopsies During Nerve-Sparing Radical Prostatectomy

    Página :S91

    E. Heinrich, L. Trojan, F. Schiefelbein, M. Michel, G. Schön

    Esquema Esquema
  • ·MP-5.01: Correlation of Histopathological Features to Tumor Size Among Patients with T1a Renal Tumors

    Página :S91

    D. Lim, M. Abdelhady, S. Pautler, J. Izawa, J. Chin

    Esquema Esquema
  • ·MP-5.02: Prognostic Value of Lymphatic Vessel Density and Lymphangiogenesis in Upper Tract Urothelial Carcinoma

    Página :S92

    M. Fernandez, C. Bolenz, L. Trojan, K. Hoffman, E. Herrmann, A. Steidler, C. Weiss, P. Ströbel, P. Alken, M. Michel

    Esquema Esquema
  • ·MP-5.03: A Retrospective Study of Implications on Survival of Histopathological Subtyping and Nuclear Grading of Renal Cell Carcinoma

    Página :S92

    Y. Kim, J. Lee, J. Huh

    Esquema Esquema
  • ·MP-5.04: Proteomic Analysis for Human Renal Cell Carcinoma Cell Clones Having Different Metastatic Potentials

    Página :S92

    Y. Kuramitsu, T. Tanaka, M. Fujimoto, S. Naito, M. Oka, K. Nakamura

    Esquema Esquema
  • ·MP-5.05: Significance of Sonoscopically Evaluated Parameters Predicting Malignant vs. Benign Renal Mass on Percutaneous Biopsy

    Página :S93

    E. Starolis, V. Keina, V. Silickas

    Esquema Esquema
  • ·MP-5.06: Clinical Follow-Up Study of Brain Metastasis of Renal Cell Carcinoma

    Página :S93

    H. Rhew, C. Sul, J. Rim, H. Kim, B. Sung, S. Kim, T. Kim

    Esquema Esquema
  • ·MP-5.07: Is Mass Size Important in Decision-Making for Nephron Sparing Surgery?

    Página :S93

    F. Önol, Y. Tanidir, B. Arslan, Y. Ilbey, E. Ozbek, S. Önol

    Esquema Esquema
  • ·MP-5.08: Analysis of Survival and Prognostic Factor of Renal Cell Carcinoma with Bone Metastasis

    Página :S94

    H. Rhew, J. Rim, C. Sul, H. Kim, B. Sung, S. Kim, T. Kim

    Esquema Esquema
  • ·MP-5.09: The Role of Lymphadenectomy in the Surgical Management of Renal Cell Carcinoma

    Página :S94

    L. Lekovski, A. Stavridis, S. Stavridis, M. Penev, A. Mickovski, S. Banev

    Esquema Esquema
  • ·MP-5.10: Troublesome Points in Renal Angiomyolipoma

    Página :S94

    K. Kim, J. Cho, H. Song, Y. Lee, S. Cho

    Esquema Esquema
  • ·MP-5.11: Increased Nuclear Factor-Kappa B Activation and Its Prognostic Significance in Human Upper Urinary Tract Transitional Cell Carcinoma

    Página :S95

    H. Yeh, W. Wu, S. Yang, L. Chang, H. Lin, H. Ke, C. Li, C. Huang

    Esquema Esquema
  • ·MP-5.12: Conventional Renal-Cell Carcinomas in Patients with Radiation Exposure, Following the Chernobyl Accident: Comparison with Spanish Cases

    Página :S95

    A. Romanenko, A. Vozianov, A. Llombart-Bosch

    Esquema Esquema
  • ·MP-5.13: Nephron-sparing Surgery for Renal Tumor in Allograft Kidney

    Página :S95

    M. Ruibal, A. Zarraonandia, P. Casas, J. Janeiro, A. Alonso, M. González-Martín

    Esquema Esquema
  • ·MP-5.14: Renal Cell Carcinoma with Macroscopic Level I Tumor Thrombus Extension into the Renal Vein: Our 7-Case Experience

    Página :S96

    O. Castillo, M. Kerkebe, M. Feria, A. Foneron, R. Sánchez-Salas, R. Campos, I. Vidal, A. Velasco

    Esquema Esquema
  • ·MP-5.15: Laparoscopic Nephroureterectomy for Upper Tract Transitional Cell Carcinoma: Results from a Single Center Experience

    Página :S96

    O. Castillo, J. Medina, M. Feria, A. Foneron, I. Vidal, R. Campos, A. Velasco

    Esquema Esquema
  • ·MP-5.16: Outcome of Cystic Renal Cell Carcinoma as Compared with Solid Tumors

    Página :S96

    A. Velasco, O. Castillo, I. San Francisco, A. Majerson, H. Rosemberg, R. Donohue, F. Balbontin, R. Cabello, I. Vidal, R. Campos

    Esquema Esquema
  • ·MP-5.17: Prognostic Stratification of Nephrectomized Patients in Renal Cell Carcinoma with Bone Metastasis

    Página :S97

    S. Hong, K. Cho, Y. Lee, D. Kim, D. Kim, S. Kim, S. Kim, Y. Kim, C. Kim, H. Kim, D. Seong, Y. Song, W. Yang, D. Lee, J. Lee, S. Cheon, B. Chung, S. Cho, I. Cho, J. Cho

    Esquema Esquema
  • ·MP-5.18: A Multidisciplinary Approach to the Management of Small Renal Tumors

    Página :S97

    C. Teigland, W. DeVoe, R. Hubbard, J. McClean, N. Mah, C. Weida, M. Lavelle, K. Kercher

    Esquema Esquema
  • ·MP-5.20: Growth Factor Expression in Renal Cell Carcinoma (RCC) and Their Relationship with Classical Prognostic Factors

    Página :S97

    M. Dominguez Esteban, A. Tejido Sanchez, O. Blanco Carvallo, A. Martin Parada, F. Bedoya, I. Vegh, J. Passas Martinez, O. Leiva

    Esquema Esquema
  • ·MP-5.21: Overexpression of HER-2 is a Prognostic Factor in Upper Tract Urothelial Carcinoma Post-Radical Nephroureterectomy

    Página :S98

    W. Li, W. Wu, Y. Wei, C. Chai, C. Li, C. Huang

    Esquema Esquema
  • ·MP-6.01: Circumcision: A Diagnostic and Therapeutic Procedure for Penile Lesions Due to Human Papillomavirus (HPV) Infection

    Página :S98

    L. Walczak, S. Dutkiewicz, S. Majewski, S. Jabloñska, A. Witeska

    Esquema Esquema
  • ·MP-6.02: The Role of Neoadjuvant Chemotherapy in Advanced Lymph Node Metastasis from Carcinoma of the Penis

    Página :S99

    Y. Thyavihally, M. Sengar, H. Tongaonkar

    Esquema Esquema
  • ·MP-6.03: The University of Chicago Technique for Pelvic Lymphadenectomy During Robotic Prostatectomy: Assessing Nodal Yield, Operative Statistics, and Complications

    Página :S99

    M. Orvieto, A. Bernstein, G. Zagaja, K. Zorn, A. Shalhav, S. Shikanov, C. Brendler

    Esquema Esquema
  • ·MP-6.04: Radical Endoscopic Treatment: Center for Practical Endoscopic Training on Cadavers as the Way to Improve Skills

    Página :S99

    V. Baca, D. Kachlik, M. Otcenasek, F. Svatos, V. Dzupa, R. Grill, J. Skubal, T. Smrzova, I. Klepacek, J. Stingl

    Esquema Esquema
  • ·MP-6.05: The Expressions of Uroplakins in a Mouse Urinary Bladder with Cyclophosphamide-induced Cystitis

    Página :S100

    G. Lee, W. Ko, H. Kim, J. Song

    Esquema Esquema
  • ·MP-6.06: Laparoscopic Versus Open Radical Nephrectomy for Renal Cell Carcinoma: Comparative Data

    Página :S100

    Y. Thyavihally, H. Tongaonkar

    Esquema Esquema
  • ·MP-6.07: Transperitoneal Laparoscopic Adrenalectomy: First Experience from the Balkan Peninsula

    Página :S100

    Z. Popov, N. Jankulovski, T. Josifovski, O. Stankov, M. Kuzmanoski, S. Saidi, S. Stavridis, A. Mickovski, O. Ivanovski, C. Dimitrovski

    Esquema Esquema
  • ·MP-6.08: Management of Clinical Stage I NSGCT Based on Pathological Stage: Role of Laparoscopic Retroperitoneal Lymph Node Dissection (RPLND)

    Página :S101

    C. Pusztai, F. Bagheri, L. Farkas

    Esquema Esquema
  • ·MP-6.09: How Much Do We Need Experts During Laparoscopic Suturing Training?

    Página :S101

    S. Van Bruwaene, M. Miserez, S. Joniau

    Esquema Esquema
  • ·MP-6.10: Evolution of Open Versus Laparoscopic Surgery: 10 Years of Changes

    Página :S101

    M. Pascual, R. Sagristà, J. Peña, J. Huguet, O. Rodríguez, D. Rengifo, A. Rosales, S. Esquena, J. Palou, H. Villavicencio

    Esquema Esquema
  • ·MP-6.11: Antegrade Mini-invasive Nephroureterectomy (AMNUE-Laparoscopic Nephrectomy, Transurethral Excision of Ureterovesical Junction and Lower Abdomen Incision)

    Página :S102

    M. Hora, J. Klecka, V. Eret, T. Urge, J. Ferda, O. Hes

    Esquema Esquema
  • ·MP-6.12: Mismatch Repair Expression in Testicular Cancer Predicts Recurrence and Survival

    Página :S102

    A. Velasco, E. Riquelme, I. Vidal, L. Frederick, O. Castillo, G. Mendez, F. Balbontin, R. Cabello, A. Foneron

    Esquema Esquema
  • ·MP-6.13: Quality of Surgery: Evaluating Pathological Findings of My First 20 Laparoscopic Radical Prostatectomies Compared with My Last 20 Open Radical Prostatectomies

    Página :S103

    S. Guzman, F. Lira, C. Parra, J. Salvadó

    Esquema Esquema
  • ·MP-6.14: Perioperative Safety and Outcomes in Robotic Assisted Laparoscopic Postatectomy: A New England Experience with 332 Cases

    Página :S103

    M. Ferreira, A. Berry, J. Hu, S. Sawh

    Esquema Esquema
  • ·MP-6.15: Return of Continence Following Robotic Prostatectomy: Early Results at 3 and 6 Months from a Cohort of 314 Men

    Página :S103

    M. Ferreira, A. Berry, J. Hu, S. Sawh

    Esquema Esquema
  • ·MP-6.16: Extrafacial Versus Interfacial Nerve-Sparing Technique for Robotic-Assisted Radical Prostatectomy: Comparison of Functional Outcomes and Side-Specific Positive Surgical Margins Rate

    Página :S104

    M. Orvieto, S. Shikanov, G. Zagaja, A. Shalhav, K. Zorn

    Esquema Esquema
  • ·MP-6.17: Video-Assisted Urinary Diversion: Minimally-Invasive Approach After Pelvic Radiation Therapy

    Página :S105

    M. Tobias-Machado, E. Wrolclawski, E. Starling, R. Juliano, A. Tavares, A. Karan, M. Neves, F. Korkes, E. Gomes, J. Silva

    Esquema Esquema

• Moderated Video Sessions

  • ·VID.01: Endoscopic Approach in Benign Ureteral Tumors

    Página :S106

    P. Geavlete, G. Nita, V. Mirciulescu, B. Geavlete

    Esquema Esquema
  • ·VID.02: Uretero-Enteric Stenosis Treated by Flexible Percutaneous Approach

    Página :S106

    P. Geavlete, R. Multescu, V. Mirciulescu, D. Georgescu, B. Geavlete

    Esquema Esquema
  • ·VID.03: Video Endoscopic Inguinal Lymphadenectomy (VEIL): Our Initial Experience

    Página :S106

    Y. Thyavihally, H. Tongaonkar

    Esquema Esquema
  • ·VID.04: Knotless Greek Bar Suture to Kidney Hemostasis and Repair: A Novel Option to Achieve Reduced Worm Ischemia Time During Laparoscopic Partial Nepherectomy

    Página :S107

    M. Tobias-Machado, E. Wroclawski, R. Juliano, C. Bezerra, E. Starling, A. Tavares, J. Silva, M. Wroclawski, L. Pertusier, E. Pedroso

    Esquema Esquema
  • ·VID.05: Early Continence with Novel Restoration of Bladder Neck Anatomy During Robotic Prostatectomy

    Página :S107

    G. Tan, J. Jhaveri, P. Chhabra, S. Rao, R. Leung, E. Vaughan, A. Tewari

    Esquema Esquema
  • ·VID.06: Laparoscopic Radical Prostatectomy: Step by Step Technique

    Página :S107

    R. Sanseverino, O. Intilla, U. Di Mauro, G. Napodano, T. Realfonso, R. Angrisani

    Esquema Esquema
  • ·VID.07: Twelve Years of Experience with Transrectal High Intensity Focused Ultrasound (HIFU) at 3 MHZ as Treatment of Prostate Cancer: Hints to a Successful Treatment

    Página :S108

    S. Thueroff, C. Chaussy

    Esquema Esquema
  • ·VID.08: Radical Prostatectomy for Locally Advanced Prostate Cancer

    Página :S108

    M. Claessens, S. Joniau, H. Van Poppel

    Esquema Esquema
  • ·VID.09: Laparoscopic Surgery of Renal Tumour Interaortocava Recurrence

    Página :S108

    J. Peña, V. Monllau, R. Ballestero, D. Rengifo, J. Palou, H. Villavicencio

    Esquema Esquema
  • ·VID.10: Transperitoneal Laparoscopic Partial Nephrectomy with Hilar Control and Clamping

    Página :S108

    R. Sanseverino, O. Intilla, U. Di Mauro, G. Napodano, T. Realfonso, A. Barela

    Esquema Esquema
  • ·VID.11: Laparoscopic Radical Cystectomy

    Página :S109

    B. Juaneda, M. Crego, P. Puig, J. Segura, C. Vallejo, S. Addla, L. Cortadellas

    Esquema Esquema
  • ·VID.12: Laparoscopic Partial Nephrectomy

    Página :S109

    M. Crego, B. Juaneda, P. Puig, J. Segura, C. Vallejo, S. Addla, L. Cortadellas

    Esquema Esquema
  • ·VID.13: Laparoscopic Retroperitoneal Lymphadenectomy for Stage I Non-Seminomatous Germ Cell Cancer: Better Results with the Same Template as Open Surgery?

    Página :S110

    M. Tobias-Machado, E. Wroclawski, E. Starling, A. Tavares, R. Juliano, E. Gomes, I. Youssef, O. Neto, M. Bicudo

    Esquema Esquema
  • ·VID.14: Radical and Staged Simplified Video Endoscopic Inguinal Lymphadenectomy (VEIL): Minimally Invasive Options to Achieved Reduced Morbidity in Penile Carcinoma Lymph Node Management

    Página :S110

    M. Tobias-Machado, E. Wroclawski, R. Juliano, E. Starling, A. Tavares, E. Gomes, J. Silva, W. Molina, M. Wroclawski, E. Pedroso

    Esquema Esquema

• Unmoderated Poster Sessions

  • ·UP.01: Comparison of 18fdg PET/CT and MRI for N-Staging of Urothelial Bladder Cancer: Correlation with Histopathologic Findings

    Página :S111

    T. Jensen, P. Holt, O. Gerke, M. Riehmann, B. Svolgaard, N. Marcussen, K. Bouchelouche

    Esquema Esquema
  • ·UP.02: Laparoscopic Surgery of the Primary Renal Lymphoma: A Difficult Case

    Página :S111

    S. Tavasoli Yosefabad, S. Falahatkar, S. Emadi, M. Akbarpour

    Esquema Esquema
  • ·UP.03: Cystoscopically-Guided Transurethral Incision of the Bladder Neck by ND: YAG Laser in Vesicourethral Stricture After Prostatectomy

    Página :S111

    M. Razaghi, B. Javanmard, I. Rezaei, A. Rezaei, M. Mohammadhosseini

    Esquema Esquema
  • ·UP.04: Retroperitoneal Lymph Node Dissection in Post-Chemotherapy Residual Masses in Testicular Germ Cell Tumors in an Indian Population: A Single Centre Experience

    Página :S111

    A. Seth, A. Kumar, P. Singh, S. Panda, N. Gupta

    Esquema Esquema
  • ·UP.05: Laparoscopic Postchemotherapy Retroperitoneal Resection of Residual Masses in Germ Cell Tumor Patients: Our Experience

    Página :S112

    F. Cabrera, G. Duque, J. Duarte, J. Passas, F. Villacampa, A. Tejido, O. Leiva

    Esquema Esquema
  • ·UP.06: Efficacy and Safety of Active Surveillance for Testicular Cancer

    Página :S112

    T. Larach, A. Krebs, B. Vivaldi, C. Díaz, A. Domenech, M. Fernández, A. Figueroa, N. Zambrano, F. Coz

    Esquema Esquema
  • ·UP.07: 20-Year Phase 1/2 Study of Single Agent Carboplatin in Metastatic Seminoma: Could it Have Been Accelerated By 72 Hr PET Scan Response?

    Página :S113

    T. Oliver, T. Powles, U. Somasundram, J. Shamash

    Esquema Esquema
  • ·UP.08: Detection of Renal Disease in a Population Investigated for Microscopic Haematuria

    Página :S113

    A. Cottrell, B. Davies, D. Gillatt

    Esquema Esquema
  • ·UP.09: Extra Adrenal Pheochromomocytoma of Urinary Bladder: A Case Report and Review of Literature

    Página :S113

    P. Sharma, P. Sharma, B. Saraswat

    Esquema Esquema
  • ·UP.10: Mineralocorticoid Expression is a Negative Prognostic Predictor in Patients with Renal Cell Carcinoma

    Página :S113

    T. Ogushi, T. Fujimura, J. Kumagai, T. Kitamura, T. Urano, S. Inoue, S. Takahashi

    Esquema Esquema
  • ·UP.11: Renal Cell Carcinoma: Atypical Clinical Manifestation

    Página :S114

    A. Ilievski, P. Ilievski, R. Nakovski, V. Jankovski, S. Jovanovski, T. Batandzioski, Z. Popovski

    Esquema Esquema
  • ·UP.12: Renal Cell Carcinoma, Sarcomatoid Variant: Our Experience of 10 Years at the Clinical Hospital of the University of Chile

    Página :S114

    M. Cuevas, J. Fullá, M. Igor, P. Diaz, O. Storme

    Esquema Esquema
  • ·UP.13: Renal Cell Carcinoma with Sarcoid-Like Stromal Reaction

    Página :S114

    A. Ibarra, J. Campero, P. Matamala

    Esquema Esquema
  • ·UP.14: Malignant Renal Mesenchymoma

    Página :S114

    A. Ibarra, P. Matamala, J. Urrutia, E. Alcalde

    Esquema Esquema
  • ·UP.15: Short- and Long-Term Surgical Outcomes of Laparoscopic Radical Nephrectomy for Kidney Cancer: A Single Center Experience in Brazil

    Página :S115

    M. Tobias-Machado, E. Starling, E. Wrolclawski, R. Juliano, A. Tavares, L. Pertusier, E. Pedroso, P. Forseto, J. Silva, E. Gomes

    Esquema Esquema
  • ·UP.16: Nephron-Sparing Surgery for Renal Tumors: Laparoscopic-Assisted Radio Frequency Ablation with Curative Intent

    Página :S115

    I. Vidal, O. Castillo, A. Velasco, A. Foneron, M. Feria, R. Campos, F. Balbontin, R. Cabello

    Esquema Esquema
  • ·UP.17: A Distinctive Translocation Carcinoma of the Kidney (“Rosette Forming”, T(6;11), Hmb45 Positive)

    Página :S115

    M. Hora, O. Hes, T. Urge, J. Ferda, J. Klecka, V. Eret, R. Bokr, M. Michal

    Esquema Esquema
  • ·UP.18: Burden of Bone Metastases From Renal Cell Carcinoma: Zoledronic Acid and Functional Independence

    Página :S116

    L. Drudge-Coates, P. Thompson, G. Muir

    Esquema Esquema
  • ·UP.19: Spontaneous Rupture of Renal Tumors

    Página :S116

    S. Alkadhi, N. Younes, A. Alani, F. Gomma, A. Alansari

    Esquema Esquema
  • ·UP.20: Green Light (532 NM) Laser Partial Nephrectomy Followed by the Suture of the Collecting System Without Renal Hilar Clamping in a Porcine Model

    Página :S116

    V. Eret, M. Hora, R. Sykora, O. Hes, T. Urge, J. Klecka, M. Matejovic

    Esquema Esquema
  • ·UP.21: Seminal Vesicle Carcinoma: 4 Clinical Cases Reported From the Clinical Hospital of University of Chile Between 1990-2005

    Página :S117

    M. Cuevas, M. Igor, J. Fullá, P. Diaz, O. Storme

    Esquema Esquema
  • ·UP.22: Bowen's Disease of the Penis: Clinical Hospital, University of Chile Experience

    Página :S117

    M. Cuevas, J. Fullá, M. Igor, P. Diaz, O. Storme

    Esquema Esquema
  • ·UP.25: Do Androgen Receptor Polymorphisms Contribute to an Increased Risk for Benign Prostate Hyperlasia (BPH)?

    Página :S117

    K. Song, C. Sul, I. Cho, D. Riley, J. Krieger

    Esquema Esquema
  • ·UP.26: Metastatic Infiltration of the Ureter: Leading Cause of Ureteral Obstruction iIn Patients Who Died From Ovarian Carcinoma

    Página :S118

    G. Bonkat, S. Wyler, U. Gϋth, R. Robin, A. Bachmann

    Esquema Esquema
  • ·UP.27: Korean Red Ginseng Reduces Ischemia/Reperfusion-Induced Bladder Oxidant Stress and Dysfunction in Rats

    Página :S118

    C. Sul, K. Kim, D. Koo, J. Shin, J. Lim, Y. Na, H. Kim, H. Rhew, K. Song

    Esquema Esquema
  • ·UP.28: The Breakdown of Regeneration Among People of Older Age Groups and Carcinogenesis

    Página :S118

    A. Pechersky, V. Pechersky, M. Aseev, A. Droblenkov, V. Semiglazov

    Esquema Esquema
  • ·UP.29: Effect of Nutritional Status on Baseline Intravesical Pressure in Women

    Página :S119

    A. Salazar, C. Montiglio, G. Sarrat, A. Miranda, E. Schwarze

    Esquema Esquema
  • ·UP.30: Nutrition Profile and Bone Loss in Prostate Cancer Patients Receiving Long-Term Androgen Deprivation

    Página :S119

    M. Tobias-Machado, P. Maia, J.L. Silva, E.G. Silva, M.L. Wroclawski, E.R. Wroclawski

    Esquema Esquema
  • ·UP.31: Robotic Assisted Radical Prostatectomy in the Renal Allograft Recipient

    Página :S119

    J. Jhaveri, G. Tan, D. Scherr, E. Vaughan, A. Tewari

    Esquema Esquema
  • ·UP.32: Robotic Radical Prostatectomy Utilizing a Custom-Made Synchronous Suprapubic Vesical Urinary Diversion Device and Anastomotic Splint: Report of Initial Series and Peri-Operative Outcomes

    Página :S120

    S. Rao, A. Mandhani, G. Tan, R. Yadav, J. Jhaveri, R. Leung, A. Te, G. Bartsch, D. Vaughan, A. Tewari

    Esquema Esquema
  • ·UP.33: Return of Orgasmic Function In Patients Undergoing Robotic Prostatectomy

    Página :S120

    S. Rao, R. Gray, R. Leung, R. Yadav, J. Jhaveri, G. Tan, E. Vaughan, A. Tewari

    Esquema Esquema  
  • ·UP.34: A Comparative Head-On Efficacy Study of 3 Monthly Goserelin 10.8 Mg, 3 Monthly Leuprolide 11.25 Mg and 3 Monthly Leuprolide 22.5 Mg with 6 Monthly Leuprolide 45mg Preparations for Treatment in Patients with Prostate Cancer

    Página :S120

    R. Sood, S. Kathuria, H. Ahmad, M. Ahir

    Esquema Esquema
  • ·UP.35: HIFU in Prostate Cancer Treatment

    Página :S121

    P. Shestiperov, Y. Alyaev, V. Grigoryan, A. Amosov, E. Bezrukov, G. Krupinov, M. Chalyy

    Esquema Esquema
  • ·UP.37: Outcome of Radical Prostatectomy According to Pathological Gleason Score

    Página :S121

    A. Figueroa, J. Lopez, B. Vivaldi, C. Diaz, A. Domenech, M. Fernandez, A. Krebs, N. Zambrano, F. Coz

    Esquema Esquema
  • ·UP.38: Should Extended Core Biopsy be a Rule for the Detection of Prostate Cancer in Gray Zone PSA?

    Página :S121

    C. Lee, T. Jeong, D. Kim, E. Kim, C. Park, Y. Jeon, N. Lee

    Esquema Esquema
  • ·UP.39: The Incidence of High-Grade Prostatic Intraepithelial Neoplasia (HGPIN) in TRUSG-Guided Prostate Biopsy Specimens: Data of the Referred Patient Population From a High-Volume Community Training Hospital

    Página :S122

    A. Bölükbasi, K. Bal, F. Þengül, A. Sezer, A. Akder Sarý, C. Öztürk

    Esquema Esquema
  • ·UP.40: The Importance of Biopsy Protocol in Terms of Correct Gleason Grading of the Patients Prior to Radical Prostatectomy: Preliminary Results

    Página :S122

    A. Bölükbasi, F. Þengül, K. Bal, A. Sezer, E. ElaaltuntaÞ, Ö. Çakmak

    Esquema Esquema
  • ·UP.41: The Association of Increased Number of Positive Prostate Biopsy Cores With Gleason Grade Upstaging Following Radical Prostatectomy

    Página :S122

    A. Bölükbasi, F. Þengül, K. Bal, A. Sezer, E. ElaltuntaÞ, Ö. Çakmak

    Esquema Esquema
  • ·UP.42: Correlation of Pre-operative Prostate Specific Antigen (PSA) With Gleason Grading in Prostate Cancer Diagnosis

    Página :S122

    K. Gyasi-Sarpong, K. Boateng, K. Aboah, P. Opoku, M. Adu-Gyamfi

    Esquema Esquema
  • ·UP.43: Comparison of the Oncologic Outcome Between Retropubic and Laparoscopic Radical Prostatectomy

    Página :S123

    O. Storme, J. Flores, M. Kerkebe, R. Parra, R. Olivares, J. Wilckes, C. Hudson, D. Varas, J. Fulla, M. Varas, N. Orellana

    Esquema Esquema
  • ·UP.44: Comparison of Surgical Outcome: Urinary Continence and Sexual Function Between Laparoscopic and Retropubical Radical Prostatectomy

    Página :S123

    O. Storme, J. Flores, M. Kerkebe, N. Orellana, R. Parra, J. Wilckes, J. Fulla, M. Varas, C. Hudson, D. Varas

    Esquema Esquema
  • ·UP.45: Role and Significance of Neo-Adjuvant Hormonal Therapy on Patients Undergoing Vattikuti Institute Robotic Radical Prostatectomy (RRP): A Case-Matched Comparative Study

    Página :S124

    S. Krane, N. Pokala, N. Patil, J. Peabody, M. Menon

    Esquema Esquema
  • ·UP.46: Mini TURP for Obstructed Patients Prior to Prostate Brachytherapy (PB)

    Página :S124

    M. Borghi, E. Becher, L. Montes de Oca, C. Cobreros, V. Chernobilsky, S. Savignano, U. Iturralde

    Esquema Esquema
  • ·UP.47: Primary Carcinoma of Seminal Vesicles: Role Of Surgery in Presence of Metastasis: Case Report

    Página :S124

    O. Castillo, A. Velasco, A. Foneron, R. Campos, I. Vidal, M. Feria

    Esquema Esquema
  • ·UP.49: Value of Complex PSA Percentage to Define Prostate Cancer Aggressiveness in Patients with Total PSA Between 2.5 And 10ng/Dl

    Página :S125

    A. Zarraonandia, F. Gómez Veiga, J. Ponce, S. Pertega, S. Breijo, D. López, L. Castelo, J. Casas, I. Rodriguez Gomez, M. González-Martín

    Esquema Esquema
  • ·UP.50: Low Dose Brachytherapy to Treat Prostate Cancer: Oncological Results

    Página :S125

    F. Gomez Veiga, A. Zarraonandia, D. Lopez, L. Castelo, A. Mariño, A. Candal, I. Rodriguez, C. Vieras, M. Gonzalez-Martin

    Esquema Esquema
  • ·UP.51: The Impact of Obesity on Laparoscopic Radical Prostatectomy

    Página :S125

    F. Cabrera, G. Duque, J. Duarte, J. Passas, F. Villacampa, A. Tejido, O. Leiva

    Esquema Esquema
  • ·UP.52: Prostate Cancer and Sexual Function after External Beam Radiotherapy, with the Use of a Cytoprotective Agent (Amifostine): The Efficacy of Sildenafil

    Página :S126

    E. Patris, T. Pantazis, G. Patris, S. Giannacopoulos, C. Kalaitzis, C. Vudalikakis, M. Koukourakis, S. Touloupidis

    Esquema Esquema
  • ·UP.53: Are There Any Differences Between Symptomatic Prostate Cancers and Asymptomatic Screened Prostate Cancers?

    Página :S126

    C. Lee, T. Jeong, D. Kim, E. Kim, C. Park, Y. Jeon, N. Lee

    Esquema Esquema
  • ·UP.54: The Multidisciplinary Uro-Oncology Team: Auditing Outcomes

    Página :S126

    M. Ezra, P. Kumar, S. Tang, N. Dahar

    Esquema Esquema
  • ·UP.55: PSA And Retention: To Do Or Not To Do?

    Página :S127

    P. Kumar, J. Saunders, O. Cole

    Esquema Esquema
  • ·UP.56: Holmium Laser as a Treatment for Anastomotic Stricture Following Radical Prostatectomy

    Página :S127

    P. Kumar, N. Saw, N. Dahar

    Esquema Esquema
  • ·UP.57: Possible Role of Vertebral Veins in the Dissemination of Prostate Cancer: Cluster Analysis of Metstatic Patterns to the Skeletal Systems with Bone Scintigrams

    Página :S127

    T. Onita, H. Sakai, T. Igawa, H. Kanetake

    Esquema Esquema
  • ·UP.58: Prognostic Factor of Early Dissemination of Radically Treated Prostate Cancer Patients

    Página :S127

    H. Urbanczyk, J. Ciechowicz, L. Miszczyk

    Esquema Esquema
  • ·UP.59: Quality-Of-Life Outcomes in Patients Undergoing Emerging Techniques for the Treatment of Localised Prostate Cancer: A Prospective Study

    Página :S128

    R. Thanigasalam, P. Stricker, P. Brenner, H. Baumert, A. Earnest, V. Patel, S. Henshall, K. Rasiah

    Esquema Esquema
  • ·UP.60: Issues Faced in the Transition From Open to Robot-Assisted Laparoscopic Radical Prostatectomy in the Contemporary Era

    Página :S128

    R. Thanigasalam, P. Stricker

    Esquema Esquema
  • ·UP.61: Does Every Patient with High PSA (>100ng/Ml) Need Prostate Biopsy?

    Página :S128

    Y. Kim, J. Lee

    Esquema Esquema
  • ·UP.62: Advanced Robotic Assisted Laparoscopic Prostatectomy Training: Building The Foundation of a Reproducible Operation

    Página :S129

    J. Davis, S. Matin

    Esquema Esquema
  • ·UP.63: Widespread Indications for Radical Prostatectomy: Does It Make Sense?

    Página :S129

    J. Djozic, J. Bogdanovic, N. Seljmesi, B. Culibrk, M. Djozic, S. Djozic, G. Marusic, E. Djozic

    Esquema Esquema
  • ·UP.64: The Effects of Naftopidil on Lower Urinary Tract Symptoms After Radical Prostatectomy

    Página :S129

    K. Ishizaka, T. Machida, M. Tanaka, N. Kawamura, K. Nakamura, T. Kamai, M. Honda, K. Arai, K. Yoshida

    Esquema Esquema
  • ·UP.65: The Study of Repeat Prostate Biopsy for the Undetected Prostate Cancer

    Página :S130

    Y. Kim, J. Lee, J. Huh

    Esquema Esquema
  • ·UP.66: Sexual Rehabilitation After Radical Retropubic Prostatectomy (RRP): Results of a Clinical Study on 40 Patients Treated with Tadalafil and Alprostadil

    Página :S130

    T. Brancato, G. Orsolini, R. D'Ascenzo, P. Nupieri, G. Paulis, R. Alvaro

    Esquema Esquema
  • ·UP.67: Sexual Function and Prognostic Factors for Post-Implant Urinary Retention after Prostate Brachytherapy

    Página :S130

    A. Rempelakos, A. Marketakis, G. Ioanidou, S. Mpisias, E. Koutsiaris, A. Papas

    Esquema Esquema
  • ·UP.68: Prostate Cancer Review: Komfo Anokye Teaching Hospital, Ghana

    Página :S131

    K. Gyasi-Sarpong, B. Awauh, K. Aboah, P. Opoku

    Esquema Esquema
  • ·UP.69: Polymorphism of CYP1a1 MSP1 and Mortality in Patients with Prostatic Cancer: Seven-Year Follow-Up

    Página :S131

    J. Fullá, C. Acevedo, M. Varas, C. Huidobro, J. Cabezas, V. Galleguillos, D. Catoni, D. Cáceres, L. Quiñones

    Esquema Esquema
  • ·UP.70: Patients with a Single Microfocus (<5%) of Gleason 6 Prostate Cancer at Biopsy: Can We Predict Adverse Pathological Outcomes?

    Página :S131

    M. Orvieto, A. Thong, S. Shikanov, S. Eggener, G. Zagaja, A. Shalhav, K. Zorn

    Esquema Esquema
  • ·UP.71: Lack of Stimulation of Histamine Release by Ozarelix, a 4th Generation GNRH Antagonist on Human Basophils

    Página :S132

    B. Denes, G. Reddy

    Esquema Esquema
  • ·UP.72: A Comparison of the Pharmacokinetics of Ozarelix: A Novel GNRH Antagonist, Administered IM Vs. SC

    Página :S132

    B. Denes, G. Reddy

    Esquema Esquema  
  • ·UP.73: Initial Experience with HIFU in Patient with Prostate Cancer

    Página :S133

    M. Borghi, L. Montes de Oca, E. Becher, V. Chernobilsky, S. Savignano

    Esquema Esquema
  • ·UP.74: Magnetic Resonance Spectrometry in Prostate Cancer Diagnosis

    Página :S133

    A. Velasco, P. Yanez, O. Castillo, I. Vidal, R. Cabello, F. Balbontin, A. Foneron, M. Feria, R. Campos

    Esquema Esquema
  • ·UP.75: Intra- and Peri-operative Outcomes Comparing Radical Retropubic and Laparoscopic Radical Prostatectomy: Our Experience

    Página :S133

    G. Duque, F. Cabrera, J. Passas, J. Duarte, A. Rodriguez, A. Tejido, F. Villacampa, O. Leiva

    Esquema Esquema
  • ·UP.76: Impact of Total Anatomic Reconstruction of the Bladder Neck in Obese Men: Continence Outcomes Following Robotic Prostatectomy

    Página :S134

    J. Jhaveri, G. Tan, S. Rao, R. Yadav, R. Leung, A. Te, E. Vaughan, A. Tewari

    Esquema Esquema
  • ·UP.77: Prostate Cancer Diagnosed at Multiple Repeat Biopsies Following Isolated High-Grade Prostatic Intraepithelial Neoplasia: Which Cancers are Significant at Radical Prostatectomy Specimen?

    Página :S134

    S. Joniau, K. De Baets, E. Lerut, T. Roskams, R. Oyen, H. Van Poppel

    Esquema Esquema
  • ·UP.78: Dd3/Pca3 (Differential Display Code 3) in Prostate Cancer Diagnosis: Experience From Czech Republic

    Página :S134

    J. Klecka, M. Hora, M. Pesta, L. Holubec, O. Topolcan, V. Eret, M. Babjuk, K. Novak, J. Stolz

    Esquema Esquema
  • ·UP.79: Detection of Prostate Cancer: A Comparative Study of the Diagnostic Value of Transrectal Biopsy Using a Standard Versus an End-Curved Biopsy Needle: About 100 Cases

    Página :S135

    S. Sallami, M. Chelif, S. Ben Rhouma, Y. Nouira, A. Horchani

    Esquema Esquema
  • ·UP.80: Influence of Weight Loss on Serum Prostate Specific Antigen Levels in Patients Who Undergo Bariatric Surgery

    Página :S135

    J. Salvadó, C. Trucco, J. Dominguez, P. Troncoso, S. Guzmán, I. San Francisco, C. Parra, N. Moya

    Esquema Esquema
  • ·UP.81: Early Prostate Cancer Recurrence Prediction Following HIFU Treatment Using AMACR and PSA Immunohistochemical Evaluation

    Página :S135

    P. Shestiperov, Y. Alyaev, E. Kogan, A. Amosov, E. Bezrukov, G. Krupinov

    Esquema Esquema
  • ·UP.82: Expression of P50 and P65 Proteins in the Development and Growth of the Prostatic Gland of Mice: Animal Model

    Página :S136

    G. Venegas, O. Espinoza-Navarro, E. Milla, I. Silva, J. Inostroza, M. Cuevas, E. Ossandon, C. Sanchez, H. Rodriguez

    Esquema Esquema
  • ·UP.83: P0 Stage at Radical Cystectomy for Bladder Cancer: What is the Outcome? Are There Any Clinical Risk Ractors? Our 7 Cases

    Página :S136

    S. Ben Rhouma, S. Sallami, K. Atallah, H. Dahmoul, F. Attyaoui, I. Kbaier, Y. Nouira, A. Horchani

    Esquema Esquema
  • ·UP.84: A Comparison of the Outcomes of Ileal and Sigmoid Orthotopic Neobladders in the Management of Invasive Bladder Carcinoma

    Página :S136

    S. Önol, F. Önol, Y. Tanidir, A. Akbas, Y. Ilbey, E. Ozbek

    Esquema Esquema
  • ·UP.85: Expression and Correlation Of Cyclooxyganase-2, Angiogenin and Vascular Endothelial Growth Factor in Human Transitional Cell Carcinoma

    Página :S137

    H. Lee, T. Kim, S. Chang, J. Huh, T. Kwon, H. Jang, W. Kim

    Esquema Esquema
  • ·UP.86: Our Experience of Holmium Laser for Recurrent Papillary Tumors of the Bladder

    Página :S137

    S. Bapat, B. Kashyapi, A. Padhye, P. Yadav, P. Mahajan, A. Bhave, Y. Sovani, Y. Kshirsagar

    Esquema Esquema
  • ·UP.87: Bladder Cancer and the Aluminum Industry: A Review of the Current Literature

    Página :S137

    T. Guzzo, T. Bivalacqua, M. Schoenberg

    Esquema Esquema
  • ·UP.88: Preliminary Experience with Video-Assisted Radical Cystectomy: Perioperative Parameters Compared with Open Conventional Procedure

    Página :S138

    E. Silva, M. Tobias-Machado, E. Starling, J. Silva, E. Wroclawski, L. Pertusier, E. Silva

    Esquema Esquema
  • ·UP.89: Concomitant Carcinoma In Situ in Patients with Superficial Bladder Tumors

    Página :S138

    P. Geavlete, D. Georgescu, I. Arabagiu, B. Geavlete

    Esquema Esquema
  • ·UP.90: Clinical Outcome of Primary Conservative Treatment for High Grade Non-Muscle Invasive Bladder Cancer

    Página :S138

    M. Fernández, M. Schultz, A. Krebs, H. Bermudez, G. Larach, R. Lyng, P. Poblete, C. Stein, I. Delgado, P. Bernier

    Esquema Esquema
  • ·UP.91: Total Pelvic Exenteration for Colorectal Cancer: A Review of General and Genitourinary Outcomes

    Página :S139

    T. Domes, P. Luke, J. Izawa, B. Taylor, P. Colquhoun

    Esquema Esquema
  • ·UP.92: Orthotopic Neobladder with Prostatic Cone Preservation

    Página :S139

    A. Foneron, O. Castillo, A. Velasco, I. Vidal, R. Campos, M. Feria, F. Balbontin, R. Cabello

    Esquema Esquema
  • ·UP.93: Prognostic Value of Re-Turb of High-Risk Non-Invasive Bladder Cancer

    Página :S140

    R. Sanseverino, A. Campitelli, G. Napodano, A. Barela, U. Di Mauro, M. Icone, A. Baio

    Esquema Esquema
  • ·UP.94: Salvage Cystectomy Indications in Bladder Cancer

    Página :S140

    O. Stakhovskyi, O. Voilenko, V. Kotov, E. Stakhovsky

    Esquema Esquema
  • ·UP.95: Orthotopic New Bladder Urethral Diversion After 106 Years of Radical Cystectomy and Ileal Conduit

    Página :S140

    M. Wishahi

    Esquema Esquema
  • ·UP.96: Bladder Substitution with Orthotopic Ileal Neobladder in Organ Confined Bladder Cancer: Results of 2 Surgical Techniques

    Página :S141

    M. Navarro Genta, R. Tagle Alegría, J. Montes Miranda, C. Barría, R. Muranda

    Esquema Esquema
  • ·UP.97: Ten-Year Experience of Urethral Cancer

    Página :S141

    A. Cottrell, A. Mevcha, D. Gillatt

    Esquema Esquema
  • ·UP.98: Quality of Life and Voiding Function Following Neobladder Formation

    Página :S141

    A. Cottrell, R. Persad, D. Gillatt

    Esquema Esquema
  • ·UP.99: The Peri-Meatus Location of Superficial Bladder Transitional Cell Carcinoma (T1): Is It a Risk Factor of Recurrence and Progression? Our 278 Cases

    Página :S142

    S. Sallami, A. Dahmani, S. Ben Rhouma, Y. Nouira, A. Horchani

    Esquema Esquema
  • ·UP.100: Transutricular Seminal Vesiculoscopy: Technical Considerations and Outcomes

    Página :S142

    S.C. Yang, W.K. Han, K.H. Rha, S.Y. Park

    Esquema Esquema

• Author Index

  • ·Author Index

    Página :S143